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Os antihiperlipidémicos são dos fármacos mais prescritos no mundo para o controlo 
dos níveis de colesterol, a mais de 20 milhões de pacientes. Devido ao seu amplo uso, 
os fármacos podem ser descartados, metabolizados e excretados no ambiente, 
potencialmente afetando organismos aquáticos. Apesar desta ampla utilização de 
antihiperlipidémicos, particularmente a sinvastatina e o ácido clofíbrico, os seus 
potenciais efeitos toxicológicos ao nível ambiental não estão totalmente caracterizados 
e compreendidos, sendo assim necessário investigá-los. Portanto, surge uma nova 
preocupação quanto ao seu potencial impacto ambiental, particularmente no ambiente 
aquático. Este trabalho visa caracterizar a toxicidade decorrente da exposição aguda 
(120 horas pós-fertilização) e crónica (60 dias) a drogas antihiperlipidémicas, 
nomeadamente sinvastatina (92.45, 184.9, 369.8, 739.6 e 1479.2 ng L-1) e ácido 
clofíbrico (10.35, 20.7, 41.4, 82.8 e 165.6 µg L-1), na espécie de peixe de água doce 
peixe-zebra (Danio rerio). As concentrações selecionadas foram implementadas em 
ambas as exposições. A análise dos efeitos incidiu sobre a observação histológica de 
tecidos dos indivíduos, no que diz respeito à determinação do sexo e dos estádios de 
maturação das gónadas, comportamento (movimentos curtos e longos, tempo de 
natação e distância total de natação), e biomarcadores de stress oxidativo (superóxido 
dismutase, catalase e glutationa peroxidase), biotransformação (glutationa S-
transferases) e peroxidação lipídica (substâncias reativas ao ácido tiobarbitúrico). No 
caso da exposição aguda, foram observadas alterações de comportamento em animais 
expostos a ambos os compostos, sendo que a sinvastatina originou hiperatividade e o 
ácido clofíbrico provocou hipoatividade em todos os parâmetros comportamentais. 
Para além disso, foi observada a inibição significativa em todos os biomarcadores em 
indivíduos expostos a sinvastatina em concentrações de 184.9 a 1479.2 ng L-1, exceto 
na catalase, parâmetro para o qual não foram reportadas diferenças significativas. A 
atividade da glutationa peroxidase selénio dependente também aumentou 
significativamente para níveis de 92.45 ng L-1. Por outro lado, em indivíduos expostos a 
ácido clofíbrico, houve um aumento significativo em todos os biomarcadores, 
geralmente em peixes expostos a concentrações de 41.4 a 165.6 µg L-1. No entanto, no 
caso da catalase e das glutationa S-transferases, na concentração mais elevada, a 
atividade diminuiu significativamente. Este estudo sugere que as exposições crónicas 
de Danio rerio a sinvastatina e ácido clofíbrico não interferem na proporção de sexo e 
nos estádios de maturação dos indivíduos. Como as defesas antioxidantes são 
importantes relativamente à capacidade do organismo no combate ao stress oxidativo, 
juntamente com efeitos a nível da locomoção, podem afetar o metabolismo ou até 
mesmo a sobrevivência dos organismos. Assim, terão de ser investigados o modo de 
ação destes dois compostos, incluindo os efeitos ao nível da disrupção reprodutiva em 
exposições mais prolongadas, de forma a observar e caracterizar os efeitos a longo-
prazo da sinvastatina e do ácido clofíbrico no compartimento aquático e nos seus 
organismos. 
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abstract 
 
Lipid-regulating drugs are one of the most prescribed medications around the world, 
to control human cholesterol levels, to more than 20 million patients. Due to their 
wide usage, pharmaceuticals can be discarded, metabolized and excreted into the 
environment, potentially affecting aquatic organisms. Despite this increasing use of 
lipid-regulating drugs, particularly simvastatin and clofibric acid, are not fully 
characterized and understood in terms of their potential toxicological effects at the 
environmental level, therefore being necessary to investigate them. Therefore, it 
emerges a new concern on their effects related to the potential environmental impact, 
particularly in the aquatic environment. This work intended to characterize the toxicity 
due to an acute (120 hours post-fertilization) and chronical (60 days) exposure to 
antihyperlipidemic drugs, namely simvastatin (92.45, 184.9, 369.8, 739.6 and 1479.2 
ng L-1) and clofibric acid (10.35, 20.7, 41.4, 82.8 and 165.6 µg L-1), in the freshwater 
species of zebrafish (Danio rerio). The concentrations hereby selected were 
implemented in both exposures. The analysis of effects focused on the histological 
observation of tissues in individuals, concerning sex determination and maturation 
stages of gonads, behavior (small and large distance, total distance and swimming 
time), biomarkers of oxidative stress (superoxide dismutase, catalase and glutathione 
peroxidase), biotransformation (glutathione S-transferases) and lipid peroxidation 
(thiobarbituric acid reactive substances). In terms of acute exposure, it was observed 
behavioral alterations in both compounds, simvastatin caused hyperactivity and 
clofibric acid provoked hypoactivity in all behavioral parameters. Moreover, it was 
observed a significant decrease in all biomarkers in individuals exposed to simvastatin 
from 184.9 to 1479.2 ng L-1, except for catalase, for which no significant differences 
were found. Glutathione peroxidase selenium-dependent activity also showed a 
significant increase at 92.45 ng L-1. On the other hand, in individuals exposed to 
clofibric acid, there was a significant increase in all biomarkers, typically from 41.4 to 
165.6 µg L-1. However, in catalase and glutathione S-transferases, in the highest 
concentration, the activity was significantly decreased.  This study suggests that the 
chronic exposure of Danio rerio to simvastatin and clofibric acid does not interfere 
with the sex ratio and maturation stages of individuals. As antioxidant defenses are 
important in terms of the capacity of the organism to overcome oxidative stress, along 
with effects in locomotion, it can affect the metabolism or even the survival of 
organisms. Therefore, further studies in terms of mode of action of these two 
compounds, including reproductive disruption effects in longer exposures, are 
required to observe and characterize the long-term effects of simvastatin and clofibric 
acid in the aquatic compartment and its organisms. 
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1. INTRODUCTION 
1.1. Pharmaceuticals in the environment 
The worldwide dispersion of xenobiotics, i.e., foreign substances or chemicals that 
are not normally produced or present in living organisms, leads to environmental 
polution. This phenomenon is generally a result of human activities, such as industrial and 
agropecuary undertakings (Embrandiri et al., 2016). Some examples of xenobiotics are 
heavy metals, fertilizers, insecticides, herbicides, dyes, solvents, agrochemicals, industrial 
chemicals, such as polychlorinated biphenyls (PCBs), hydraulics, halogenated substances, 
fire retardants, pigments, persistent organic pollutants (POPs), and pharmaceuticals 
(Reineke & Knackmuss, 1988; Dinka, 2018). The use of pharmaceuticals, namely human 
treatment drugs, and those used in veterinary medicine, to prevent and treat several 
diseases, has led to a worldwide increase in their consumption and environmental 
presence (Jelic et al., 2011). Some pharmaceuticals are discarded directly into the wild, or 
metabolized and excreted into the environment, potentially affecting aquatic organisms 
and causing short and long-term effects, analogous to those observed in humans, 
including toxicological interactions with varied pathways and receptors (Henschel et al., 
1997). Ecotoxicology describes the relation between chemical pollutants, the 
environment where they are released and the organisms present (Segner, 2011). The 
human excretion of pharmaceutical compounds, in some cases, reaches 40% to 90% in its 
original form or/and as their active metabolites, through urine and feces, providing an 
entrance source of these compounds into the sewage, such as in the case of direct discard 
into the environment, when pharmaceuticals are not properly eliminated (Jones et al., 
2005; Kumar & Xagoraraki, 2010). The scientific knowledge concerning the environmental 
fate and effects of pharmaceuticals has increased significantly in the past several years, 
demonstrating the toxicity of these compounds in the aquatic ecosystem (Richardson et 
al., 2005; Kumar & Xagoraraki, 2010; Ojemaye & Petrik, 2019).  
The presence of pharmaceuticals, namely the parental substances, metabolites, 
and transformation products, in the aquatic compartment is, at present, a concerning 
issue, due to the increase and extensive use of this type of contaminants in medicine. 
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Environmental exposure to drugs that are continuously released into the environment 
can have various deleterious effects on living individuals. The occurrence of 
pharmaceuticals has been detected worldwide, in sewage treatment plants, seawater, 
surface water and groundwater (Nikolaou et al., 2007). The most common 
pharmaceuticals found in the environment are included in specific pharmaco-therapeutic 
classes, such as analgesics, anti-inflammatories, antidepressants, antiepileptics, 
antibiotics, beta-blockers, lipid regulators (Jelic et al., 2011). Among the pharmaceuticals 
most commonly detected in water treatment plant effluents, one can find simvastatin 
(Portugal, <369.8 ng L-1) (Salgado et al., 2010), naproxen (Germany and Taiwan, 0.017 – 
0.52 µg L-1) (Ternes, 1998; Lin et al., 2005), diclofenac (Greece and Germany, 0.01 – 0.56 
µg L-1) (Heberer et al., 2001), metoprolol (Germany, 0.025 – 2.2 µg L-1) (Hirsch et al., 1996; 
Ternes, 1998), triclosan (USA and Canada, 0.01 – 2.7 µg L-1) (McAvoy et al., 2002; Boyd et 
al., 2003), ibuprofen (Switzerland and UK, 0.002 – 2.972 µg L-1) (Buser et al., 1998; 
Roberts & Thomas, 2006), clofibric acid (Germany and UK, 0.044 – 4.55 µg L-1) (Stan & 
Heberer, 1997; Roberts & Thomas, 2006), benzafibrate (Germany and Canada, 0.02 – 4.6 
µg L-1) (Ternes, 1998; Miao et al., 2002) and carbamazepine (Germany and Taiwan, 0.042 
– 6.3 µg L-1) (Ternes, 1998; Lin et al., 2005). This scenario is a direct consequence of the 
general inefficacy of wastewater treatment plants (WWTPs) in removing these 
substances. The results of previous investigations show that WWTPs are mostly 
ineffective in the removal of pharmaceuticals (Hignite & Azarnoff, 1977). Therefore, 
WWTPs constitute the main source of entry of these compounds into the environment 
(Lin et al., 2010). Physicochemical properties of drugs, such as biodegradability, 
lipophilicity, solubility, photosensitivity, and volatility, as well as operation and climate 
conditions during the process of treatment, can affect the removal rate of 
pharmaceuticals from sewage water (Boxall, 2004; Gracia-Lor et al., 2012). However, 
pharmaceuticals are resistant to metabolic degradation and to most commonly used 
wastewater treatment processes, being persistent in the environment (Hignite & 
Azarnoff, 1977). 
Pharmaceutical acute and chronic exposure can have various effects on organisms, 
especially in the gills, one of the primary organs in direct contact with contaminants, and 
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liver, which is responsible for the detoxification and metabolism of the organisms (El-Saad 
& Elgerbed, 2010; Omar & Mahmoud, 2017). Drugs also act in the central nervous system 
(CNS), damaging its proper functioning, affecting behavior (Monat-Descamps & 
Deschamps, 2012). Many pharmaceuticals, such as antidepressants, selective serotonin 
reuptake inhibitors (SSRIs), hormones, antihistamines, and various psychiatric drugs, can 
alter the behavior of individuals. Changes in behavior can be related to alterations in 
feeding, movement, reproduction, activity and can have various sources of action 
(McFarland et al., 2014). Therefore, behavior can affect the survival of organisms, having 
consequences even at the population level, being a relevant issue to investigate (Brewer 
et al., 2001). Pharmaceuticals may also alter the intracellular homeostasis, i.e., self-
regulating processes by which living organisms try to maintain stability, assuring their 
survival (McEwen, 2016), disrupting mitochondrial proper function and forming free 
radicals (Nihat Ozaydin, 2017). Some drugs are also genotoxic, acting directly or indirectly 
in the DNA (Prieto Garcia et al., 2012), or nephrotoxic, causing deleterious modifications 
in excretion, metabolism, or favoring endocrine disruption (Voss et al., 2005). Endocrine 
disruption is commonly characterized by alterations in hormonal activity, through 
changes in the general development and reproduction of individuals. Generally, 
endocrine disruptors (EDCs) are highly lipophilic, with considerable bioaccumulation 
potential, i.e., significant tendency of this pharmaceuticals to accumulate gradually in 
living organisms (Wang, 2016). EDCs have also been associated with the disruption of 
mental and immune systems and impaired behavior. Therefore, it is important to 
understand the effects that endocrine disruptors have in individuals, which are not yet 
fully understood (Embrandiri et al., 2016; Lauretta et al., 2019).  
As previously exposed, the exposure to contaminants may result in a huge variety 
of effects, at the cellular and biochemical levels, that can be measured by biochemical 
biomarker assessment (Committee on Biological Markers of the National Research 
Council, 1987). A biomarker is any measurable response that reflects cellular or 
biochemical alterations according to the exposure to xenobiotics or of host response 
(Committee on Biological Markers of the National Research Council, 1987). Biomarkers 
can include various types of analysis, including behavioral, biochemical and histological 
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assessment (Committee on Biological Markers of the National Research Council, 1987). 
Biochemical and physiological processes can result from alterations from endogenous or 
exogenous sources, e.g., after the exposure to contaminants, enabling the evaluation of 
toxicological effects and being possible to imply the impact in different trophic levels, 
from the individual to the environment level. The presence of xenobiotics in the wild 
suggests a pollution frame, which leads to changes in organisms resulting in toxicity (Ayas 
et al., 2007). Biomarkers can detect the primary effects in the individual exposed to 
contaminants, e.g. at the behavioral and biochemical level, even at low concentrations, 
which makes them important tools to assess environmental pollution and consequent 
effects (Lionetto et al., 2003). 
 
1.2. Endocrine disruptors 
The reproductive physiology in fish consists of sexual and gonadal development of 
both males and females. Various organs are involved in the sex development and 
maturation of individuals. The primary organ that regulates these processes is the 
hypothalamus, which produces gonadotropin-releasing hormones, which act in the 
pituitary gland, which releases gonadotropins. These hormones stimulate gametogenesis, 
i.e., the development of oocytes or spermatozoids in the gonads in fish (Bogers, 2008). 
Some xenobiotics, known as Endocrine-Disrupting Chemicals (EDCs), can disrupt the 
regulation of the hypothalamus-pituitary-gonadal axis, by mimicking endogenous 
hormones. Generally, EDCs bind and/or activate receptors for hormones, mimicking the 
original hormone (agonist) or blocking the receptors, leading to its inhibition (antagonist) 
(Leino et al., 2005). Some of the effects observed after exposure to EDCs are the 
development of intersex, inhibition of gametogenesis, decrease in fertility and 
modification of the gonadosomatic index (Carnevali et al., 2018). EDCs can also alter the 
normal functioning of the endocrine system, interfering with hormone activity and, as 
mentioned before, altering the development, reproduction, and behavior of individuals 
(Embrandiri et al., 2016; Lauretta et al., 2019). EDCs can affect the early life stages of 
individuals, through gametogenesis disruption, and may also disrupt the ontogenic 
development (Mnif et al., 2011).  
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EDCs that disrupt the action of sex hormones may result from natural sources, 
such as natural estrogens or phytoestrogens present in leguminosae and soy 
(isoflavones), or be man-made. From hundreds of thousands of anthropogenic chemicals, 
one thousand may have endocrine-acting properties, by the disruption of hormone 
activity in living organisms (Bogers, 2008; Crusselle-Davis & Archer, 2010). Some examples 
of this type of EDCs of anthropogenic origin are pharmaceuticals, including estrogens, 
antibiotics, beta-blockers, antiepileptics, pesticides, plastics, metals, industrial chemicals 
and lipid regulating drugs, such as statins and fibrates (Louis & Stoker, 2015). Some of the 
biological endpoints often investigated after exposure to EDCs are gross morphology, 
including secondary sexual features, as well as secondary sexual characteristics, hepato or 
gonadosomatic index, levels of liver vitellogenin (VTG), plasma concentrations of 
androgens and estrogens, and histology of gonads or liver (Bogers, 2008). One of the 
most sensitive and important endpoints of exposure to EDCs is the histology of gonads, 
for example, through the determination of sex ratio and maturation stages of individuals 
(Bogers, 2008). According to Leino et al. (2005), and considering the ovaries, exposure to 
estrogen receptor agonists, androgen receptor agonists, androgen receptor antagonists, 
and steroid metabolism can affect the development and maturation of oocytes, which 
can reduce or cease ovulation. EDCs may also affect the testes, and in this case, their 
effects are more variable, possibly resulting in the hyper-production of sperm, caused by 
androgen receptor agonists and aromatase inhibitors, and degenerative alterations, 
caused by estrogen receptor agonists (Leino et al., 2005). Several guidelines conducted in 
fish use sex ratio and gonadal maturation stages as an endpoint, indicating estrogen, 
androgen and steroidogenic activity, such as the Medaka Extended One-Generation 
Reproduction Test (OECD, 2015) and the Fish Sexual Development Test (OECD, 1984). 
Danio rerio was suggested as a model organism for the assessment of EDCs effects in 
terms of gonad development (Eimon & Ashkenazi, 2010).  
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1.3. Behavior 
Behavior is an orderly sequence of actions controlled by the peripheral (PNS) and 
central nervous system (CNS), as well as a display of processes that assure the survival of 
the individual, at the biochemical, genetic and physiological levels (Benson et al., 2010). 
Internal and external stimuli can alter the behavior of the organisms, thus having an 
impact on their survival (Sloman & Mcneil, 2012). Behavioral traits may result from 
altered physiological processes due to exposure to external contaminants, and 
consequently, behavioral changes have been generally used to assess the effects of 
xenobiotics in the aquatic compartment (Scott & Sloman, 2004). Aquatic organisms, 
namely fish, represent ideal models for behavioral evaluation after the exposure to 
contaminants. They have complex behaviors, are in direct and constant contact with the 
source of contamination present in their environment, are ecological relevant in terms of 
natural systems, are easy to maintain in the laboratory, and are able to come into 
reproductive readiness in short periods of time, i.e., they have several reproductive 
periods during the year in several species of fish (Kane et al., 2005). Consequently, the 
behavioral assessment in fish is considered as an integral part of modern toxicological 
assays, because this can be a specific, reliable and sensitive method to evaluate chemical 
effects (Moser, 2010).  
Behavioral alterations can be a toxic response to exposure to certain compounds 
(Moser, 2010). There are a large number and types of environmental chemicals that can 
alter behavior. According to Grue et al. (2002), they can be classified into eight categories. 
Narcotic chemicals, i.e., low molecular weight solvents, can cause narcosis, and 
consequently, they result in hypoactivity and reduced responsiveness of the individual, 
while excitatory agents can cause oxidative phosphorylation, resulting in hyperactivity 
and hyperreactivity (Grue et al., 2002). Metals originate tissue damage or biochemical 
impairment, disrupting feeding activity and reproduction, whereas organometals can 
cause nerve tissue damage, affecting reproduction (Grue et al., 2002). Cholinesterase 
inhibitors, i.e., organophosphates, carbamates, and many others, can cause hypoactivity 
and behavioral depression (Grue et al., 2002). On the other hand, reactive chemicals, such 
as acrolein and benzaldehyde, can cause electrophilic reactions, affecting coordination 
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and causing hyporeactivity, while central nervous system (CNS) seizure agents, i.e., 
pyrethroids and organochloride pesticides, act directly on the CNS, causing seizures, 
hyperactivity, ataxia, convulsions and affect coordination (Grue et al., 2002). Finally, 
endocrine disruptors, affect mainly reproductive behavior (Grue et al., 2002). 
One example of behavioral testing developed with fish is avoidance and attraction, as the 
individual normally avoids the contaminated area if the chemical induces avoidance, as 
other contaminants can have attractive responses (Brewer et al., 2001). Respiratory 
patterns are also behavioral biomarkers, as the contaminant can have several effects on 
the frequency and amplitude of opercular movements (Diamond et al., 1990). Intra and 
interspecific interactions are other examples of the behavioral monitoring. The 
hypoactivity and hyperactivity, prey capture, predator avoidance, scototaxis (preference 
for light or dark), and reproduction can have a causal linkage with the fate of the 
population (Laurence, 1972; Steele, 1983). Another type of testing involves the analysis of 
swimming patterns, as the individuals can develop altered locomotory responses, and the 
frequency of swimming movements and duration of activity can change due to the 
exposure to xenobiotics (Little & Finger, 1990; Brewer et al., 2001). Movement analysis is 
often conducted by automated biomonitoring systems because of their sensitivity, 
involving the quantification of swimming patterns and videography, such as Zebrabox 
from Viewpoint (Smith & Bailey, 1988; Miller et al., 2009). Using this automated system, 
several parameters can be measured, including velocity, acceleration, total distance 
traveled, angles, swimming time, and horizontal and vertical distribution of individuals.  
1.4. Biochemical parameters 
One of the most recurrent responses to chemical compounds involves the 
activation of metabolic defenses, generally by the activation of phase I of enzymatic 
complexes, modulating phases II and III of metabolism (Holth et al., 2008). Metabolic 
defense mechanisms usually increase the hydrophilicity of xenobiotics through hydrolysis, 
reduction, oxidation and/or especially conjugation, which ultimately, but not always, can 
lead to the transport and excretion of the toxicant (McFarland et al., 2014). Cytochrome 
monooxygenases P450 enzymes (CYP450) are the major enzymes in phase I of 
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metabolism, oxidizing lipophilic into hydrophilic compounds (Sharma et al., 2012). 
Commonly, the poor coupling of the CYP450 catalytic cycle results in the continuous 
production of reactive oxygen species (ROS), that are relevant in signaling pathways and 
can be responsible for oxidative stress (Banerjee & Ghosh, 2016). 
Most xenobiotics are known to cause hyperproduction of reactive oxygen species 
(ROS) and oxidative stress after being metabolized. Oxidative stress is defined as an 
imbalance between the production of ROS and antioxidant defenses, through the activity 
of several enzymes in the cytoplasm, mitochondria and peroxisomes (Betteridge, 2000). 
ROS are chemically reactive molecules that are produced during the oxidative metabolism 
in mitochondria and as a cellular response to xenobiotics (Ray et al., 2012). Although ROS 
are often associated with oxidative stress, they also are signaling molecules that regulate 
biological and physiological processes (Schieber & Chandel, 2014). Redox signaling is 
relevant in terms of cellular differentiation, prevention of aging and tissue regeneration 
(Schieber & Chandel, 2014). Thus, oxidative stress is present when there is a 
hyperproduction of ROS that exceeds the capacity of the cell to deploy an antioxidant 
response (Ray et al., 2012). Large varieties of substances that were already found in the 
water, including pharmaceuticals, can cause oxidative stress to aquatic species 
(Valavanidis et al., 2006). Some examples of enzymes that are involved in the antioxidant 
defense mechanisms, and that are used as biomarkers of oxidative stress, are superoxide 
dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx).  
Superoxide dismutase is found in three different forms: extracellular SOD, SOD 
containing manganese in the mithocondria (MnSOD) and SOD containing copper and zinc, 
found in the cytoplasm (Cu-ZnSOD) (Lumb, 2017). SOD constitutes protection against the 
radical superoxide (O2-) toxic effects, as it catalyzes its dismutation into hydrogen 
peroxide (H2O2) and molecular oxygen (O2). Although hydrogen peroxide is not a reactive 
oxygen species, it is still an oxidizing agent that causes oxygen toxicity. In that way, SOD 
consists of cellular defense against ROS (Hayyan et al., 2016). 
As the hydrogen peroxide is continuously produced in the organism, two enzymes 
ensure its removal, i.e. catalase (CAT) and glutathione peroxidase (GPx) (Lumb, 2017). 
CAT acts only against hydrogen, methyl and ethyl peroxides (Lumb, 2017). It is part of the 
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antioxidant defense system that exists in peroxisomes (Modesto & Martinez, 2010), 
where many enzymes that are responsible for the elimination of hydrogen peroxide are 
located (Djordjević, 2004). Its primary function is the reduction of hydrogen peroxide, into 
water and molecular oxygen (Aebi, 1984), which prevents the conversion to hydroxyl 
radical and other even more toxic ROS (Djordjević, 2004). 
GPx is found in multiple forms, all containing selenium as the catalytic metal 
(Blondet et al., 2018). It is found in the cytoplasm and mitochondria and acts in a wider 
range of peroxides, in the way that it can reduce organic peroxides unlike CAT and 
reactive species originated by lipid peroxidation (Cohen & Hochstein, 1963; Tappel, 1984; 
Flohé, 1985). GPx also acts against hydrogen peroxide, by the conversion of reduced 
glutathione (GSH) and hydrogen peroxide into water and oxidized glutathione, a dimer of 
reduced glutathione (GSSG) (Blondet et al., 2018). The tripeptide glutathione in its 
reduced form (GSH) has many biological roles including protection against ROS and 
electrophiles, or as a cofactor for many other enzymes (Ray et al., 2012). It acts directly as 
antioxidant defense, and it is present in various metabolic processes. Glutathione stores 
cysteine and nitric oxide, transporting also the latter, and it takes part in the functioning 
of transcription factors involved in redox signaling, being also responsible for the 
detoxification of various xenobiotics and endogenous substances (Lushchak, 2012). 
Glutathione reductase is responsible for the maintenance of the supply of reduced 
glutathione, at a cellular level, recycling the oxidized into the reduced form, and in turn 
maintaining the antioxidant capacity of glutathione (Couto et al., 2016). Considering their 
intimate interconnection, GPx, glutathione (both forms) and glutathione reductase are 
altogether present in hepatocytes, allowing glutathione-mediated detoxification (Blondet 
et al., 2018). 
As mentioned before, drug metabolism is characterized by three phases (Banerjee 
et al., 2016). The activity of metabolic components of phase I and II have regularly been 
used as biomarkers, i.e., by the increase or decrease in enzymes` activity, as a result of 
the presence of xenobiotics, such markers can be used to estimate the toxic effects in 
aquatic organisms (Holth et al., 2008). One example of this type of enzymes is phase II 
metabolic isoenzymes glutathione S-transferases (GSTs). Glutathione S-transferases are a 
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set of enzymes that lead to the conjugation of reduced glutathione with electrophilic 
centers, resulting in the metabolism and detoxification of xenobiotics (Ray et al., 2012). 
Consequently, it is considered one of the best examples of enzymes involved in phase II of 
biotransformation (Bradford, 1976; Modesto & Martinez, 2010). In that way, GSTs 
prevent the interaction of xenobiotic substrates with nucleic acids and cellular proteins 
(Dzoyem et al., 2014). GSTs can also transport proteins and some of their isoenzymes can 
reduce organic hydroperoxides and are responsible for the isomerization of unsaturated 
substances, protecting the organism against oxidative stress, and therefore, oxidative 
damage (Rahman, 2007; G. S. Smith, Walter, & Walker, 2013; Dzoyem et al., 2014). 
Lipid peroxidation can result because of the depletion or inefficacy of the previous 
oxidative damage preventive measures (Castell et al., 1997). Oxidative damage can occur 
due to the hyperproduction of ROS, by an imbalance between ROS production and their 
scavenging (Sharma et al., 2012). It affects mainly proteins (denaturation), nucleic acids, 
carbohydrates and lipids (peroxidation) (Sharma et al., 2012). Therefore, oxidative 
damage can affect lipoproteins, cellular membranes and molecules containing lipids, and 
can lead to structural tissue damage and eventually to cell death by apoptosis or necrosis 
(Meena & Naik, 2019). Free radicals interact with lipids present in membranes, 
particularly unsaturated fatty acids (Halliwell, 2009; Sies, 1985). This process involves 
hydrogen removal from a carbon atom, with the insertion of oxygen, leading to the 
formation of lipid peroxyl radicals and hydroperoxides (Ayala et al., 2014). As secondary 
products, various aldehydes are formed, such as malondialdehyde-like substances (Ayala 
et al., 2014). The production of aldehydes (malondialdehyde-like substances) and 
hydrocarbons lead eventually to the loss of membrane integrity (Dzoyem & Eloff, 2014). 
Malondialdehyde is the main chemical produced by the oxidation of polyunsaturated 
fatty acids (Lykkesfeldt, 2007). It can be enzymatically metabolized or it may react with 
DNA, cells or tissue proteins, forming adducts, which results in lipid peroxidation (Ayala et 
al., 2014). In that way, malondialdehyde is mainly produced by the oxidation of 
polyunsaturated fatty acids, being a more reliable and comprehensive indicator of the 
total amount of final products of lipid peroxidation (Lykkesfeldt, 2007). Lipid peroxidation 
may be expressed as the content of thiobarbituric acid reactive substances (TBARS), i.e., 
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malondialdehydes and other thiobarbituric acid reactive substances. It is the oldest but 
still the most used methodology for the measurement of lipid peroxidation, by the 
quantification of malondialdehyde-like compounds (Dasgupta & Klein, 2014). 
1.5. Simvastatin 
 
 
 
Figure 1 – Chemical structure of SIM (Adapted from Alarfaj et al., 2012) 
 
Lipid-regulating drugs are one of the most prescribed medications around the 
world, to control human cholesterol levels, to more than 20 million patients (Davidson, 
2009), with an expected global market size of 22.6 billion USD by 2022 (Research and 
Markets, 2018). According to the Infarmed – Portuguese National Authority for Medicines 
and Health Products, I.P., the consumption of lipid-regulating drugs has increased for 
decades. Over the years, the cost of antihyperlipidemic drugs has decreased drastically, 
favoring the increase in its consumption. If the price of such drugs remained constant 
between 2010 and 2013, the Portuguese population would have spent 129 million € in 
that period (Infarmed I.P., 2013). 
There are several lipid-regulating drugs, such as inhibitors of absorption of 
cholesterol, nicotinic acid, fish oil derivatives and fibrates, but statins are the 
predominant group (Rang et al., 2007). In 2013, 90% of lipid-regulating drugs sold in 
Portugal, corresponded to statins, and the other 10% were generally fibrates (Infarmed 
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I.P., 2013). Some examples of statins are lovastatin, pravastatin, atorvastatin, 
rosuvastatin, fluvastatin, pitavastatin, and simvastatin (Rang et al., 2007). Statins exert 
their therapeutic activity by inhibiting 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-
CoA) reductase (Rang et al., 2007; Davidson, 2009). HMG-CoA reductase catalyzes the 
conversion of HMG-CoA to mevalonic acid. Thus, the most evident effect of statins is the 
reduction of plasma low-density lipoproteins (LDL), some reduction in plasma 
triglycerides and an increase in high-density lipoproteins (HDL) (Rang et al., 2007). They 
constitute the first therapeutic option to lower LDL (Stroes, 2005).  
According to Infarmed I.P. (2013), the most sold statin in Portugal is simvastatin 
(SIM). SIM (Figure 1) acts as an inhibitor of the production of cholesterol in the liver 
(Germershausen et al., 1989). After ingestion, SIM is hydrolyzed, producing a metabolite, 
in a β-hydroxy acid form, that is structurally similar to HMG-CoA (Vickers et al., 1990). By 
competition, it inhibits HMG-CoA reductase, reducing the quantity of mevalonic acid, a 
cholesterol precursor (Germershausen et al., 1989).  
Simvastatin can also increase mitochondrial and peroxisomal β-oxidation of fatty 
acids (Park et al., 2016). β-oxidation and the Krebs cycle are closely related to the electron 
transport chain. In turn, the final electron acceptor of the electron transport chain 
consists in O2, which leads to the production of H2O, and ultimately to the formation of 
ROS, such as O2-, HO- and H2O2 (Speijer et al., 2014). The production of reactive oxygen 
species can, therefore, lead to oxidative stress, and ultimately to oxidative damage. The 
degradation of fatty acids has the primary goal of the formation of acetyl-CoA, to serve as 
a carbon and energy source, essential for the metabolism of the individual. This process 
can lead to behavioural changes in organisms due to changes in the input of energy 
(Orton & Parker, 1982). 
SIM is biotransformed by the cytochrome P450 in the liver o fish, particularly by 
the CYP3A4 isoform. Subsequently, it undergoes glucuronidation, a reaction catalyzed by 
UDP-glucuronosyltransferases (UGTs) (Prueksaritanont et al., 2002). The metabolism of 
SIM produces at least four primary metabolites (K. H. Kim et al., 2011).  
Considering its use, SIM is released into the sewage system, and ultimately may be 
discharged into the aquatic compartment, where its photodegradation rate is minimal 
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(<0.45% during three days) and no degradation product is detected (Sawant & Barge, 
2014). Water hydrolysis is dependent on pH and temperature. The higher these values, 
i.e., higher than pH=7 and 60°C, the faster is the hydrolysis process (Álvarez-Lueje et al., 
2005). 
The occurrence of SIM in wastewater has been reported in various studies, in 
multiple countries, such as Greece, with concentrations reaching 718 ng L-1, in 
wastewater influents (Papageorgiou et al., 2016); in the UK, reaching 115 and 5 ng L-1, in 
wastewater influents and effluents, respectively (Kasprzyk-Hordern et al., 2009); and in 
Spain, 7.5 ng L-1, in a drinking water treatment plant (Boleda et al., 2011). Samples from 
the river Danube also reported a concentration of 0.04 to 0.7 ng L-1 (Martín et al., 2011). 
There are only a few studies regarding the effects of SIM in aquatic organisms. 
Some of them showed that this compound can lead to a disruption in the reproduction 
and development (endocrine disruption), compromising the populational growth of the 
amphipod Gammarus locusta (Neuparth et al., 2014); it can also affect the development 
time and growth rate of harpacticoid copepods (Dahl et al., 2006). Ellesat et al. (2010) 
reported a dose-response toxic effect in primary hepatocytes of Oncorhynchus 
mykiss exposed to simvastatin (1 to 200 mg L-1), by the reduction of metabolic activity and 
stability of membranes. A significant decrease in the development rate was identified 
in Nitocra spinipes exposed to SIM (810 mg L-1 during 96h) (Dahl et al., 2006). A decrease 
in larval length and an increase in morphological abnormalities were also identified 
in Danio rerio (Ribeiro et al., 2015). Strzyzewski et al. (2013) have identified the reduction 
of oxidative stress and lipid peroxidation by simvastatin. On the other hand, there was an 
increase in GSTs activity and a decrease in SOD and CAT activity in Danio rerio larvae, 
during 80h of exposure (Cunha et al., 2016). Thus, SIM seems to have antioxidant 
properties. 
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1.6. Clofibric acid 
 
 
Figure 2 - Chemical structure of CA (Adapted from Kim et al., 2014) 
 
Some of the fibric acid derivatives, commonly known as fibrates, are bezafibrate, 
ciprofibrate, gemfibrozil, fenofibrate, and clofibrate. Fibrates reduce the levels of very-
low-density lipoproteins (VLDL, precursors of LDL) and triglycerides, reducing LDL and 
increasing HDL, as well. Fibrates can interact with hepatic peroxisome proliferator-
activated receptors (PPARs), that regulate the transcription of genes encoding enzymes 
involved in the synthesis and secretion of lipids, and of the β-oxidation of fatty acids 
(Michalik et al., 2006). The main principle of action of fibrates is the activation of PPARα, 
that activates lipoprotein lipase, which results in the decreasing formation of VLDL (Rang 
et al., 2007). The reduction of plasmatic cholesterol is probably the outcome of two major 
processes: the increase in excretion of cholesterol derived from body tissues and the 
inhibition of the hepatic synthesis of cholesterol (Rang et al., 2007). 
Clofibrate, etofibrate, and etofyllinclofibrate can be hydrolyzed into clofibric acid 
(2-(4-chlorophenoxy)-2-methylpropanoic acid) (Figure 2), which is the active metabolite 
that circulates in plasma and it is believed to be responsible for the hypolipidemic 
properties of these fibrates (Daughton & Ternes, 1999). Clofibric acid induces the 
enzymatic activity of hepatic peroxisomes, through binding to the nuclear receptor PPAR, 
increasing the number and size of the peroxisomes, and consequently their enzyme load 
and activity. This leads to an increase in β-oxidation of fatty acids (Orton & Parker, 1982). 
This process can take place in the mitochondria and the peroxisomes. The degradation of 
fatty acids has the primary goal of the formation of acetyl-CoA, to serve as a carbon and 
energy source, essential for the metabolism of the individual. Subsequently, CA 
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undergoes biotransformation, by the cytochrome P450, particularly the CYP4A isoform 
and glucuronidation (Orton & Parker, 1982). The excretion of CA occurs mostly through 
urine. While 3 to 20% of this compound can be excreted in its original form, it is generally 
conjugated and/or excreted as a glucuronic acid conjugate, after the glucuronidation 
process (Walmsley, 1985). Three metabolites have been identified for clofibric acid: 
hydroxyisobutyric acid, lactic acid and 4-chlorophenol (Salgado et al., 2012). 
The occurrence of CA in wastewater has been reported in several studies, in many 
countries, such as the UK, with concentrations ranging from 1 to 57 ng L-1, in wastewater 
influents (Kasprzyk-Hordern et al., 2009); in Canada, ranging from 101 to 175 ng L-1, in 
surface water of the Detroit River and Hamilton Harbour (Metcalfe et al., 2003); in China, 
with maximum values of 56.2 and 44.9 ng L-1, in wastewater influents and effluents, 
respectively (Sui et al., 2011); and in Korea, with concentration reaching 65 and 6 ng L-1, in 
wastewater influents and effluents, respectively. According to the results obtained by 
Buser et al. (1998), there is evidence of resistance to sewage treatment and degradation 
in water, where CA is predicted to persist for approximately 21 years. However, a more 
recent study reported a high photodegradation rate of this compound, with a half-life 
period of 50 h when exposed to natural light. Its persistence in the aquatic compartment 
seems to be related to the quantity of organic matter and nitrates, or by the presence of 
hydroxyl and other free radicals, that can lead to the photochemical loss (Packer, Werner, 
Latch, McNeill, & Arnold, 2003). 
There are only a few studies regarding the effects of CA in aquatic organisms. 
Some of them showed that this compound can decrease the growth rate of rainbow trout 
by 50% (from 5.27 to 2.67% per day), in organisms exposed to clofibric acid ranging from 
0.1 to 10 µg L-1 during 28 days (Owen et al., 2010); it can also increase the production of 
superoxide radicals and MnSOD and SOD total activity in humans (Strzyżewski et al., 
2013); increase in the CAT activity in Gambusia holbrooki (Nunes et al., 2004) and it can 
lead to the hyperproduction of ROS in rodents (Qu et al., 2001). There is evidence that CA 
can disrupt the reproductive system, affecting the development and reproduction of 
individuals, through alterations in endocrine control, i.e., by the reduction of cholesterol, 
that is used to synthesize hormones (Dahl et al., 2006; Owen et al., 2010).  
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1.7. Zebrafish 
Zebrafish, Danio rerio, is a freshwater fish species, originally from South Asia 
belonging to the family Cyprinidae. This species constitutes an alternative animal model 
in several areas of biological sciences, including Toxicology and Ecotoxicology. Zebrafish is 
a good bioindicator in terms of ecotoxicological effects of contaminants in living 
organisms, because of its sequenced genome, also being similar to humans in terms of 
biological systems (Dooley & Zon, 2000). Breeding and maintenance of individuals are 
easy to perform in the laboratory, allowing it to be considered as a model organism for 
vertebrate biology studies (Dooley & Zon, 2000). Its rearing is made under controlled 
conditions, regarding the temperature of the water, pH, conductivity, dissolved oxygen 
and other factors (OECD, 2013). Its use in ecotoxicology testing is due mainly to its easily 
understandable and observable behavioral responses, as well as the morphological 
characteristics of its embryos, that are relatively large and transparent, which enables the 
analyses of alterations or malformations (Dahm, 2006). Also, under controlled conditions, 
it allows the production of a large number of eggs, having a short reproductive cycle, in 
which the full maturity is reached in 3 months (Hill et al., 2005). D. rerio is a standard 
species in ecotoxicology assays, assessing the relationship between xenobiotics and 
biological systems (OECD, 2013). The use of zebrafish embryos is yet to be regulated by 
current European Union legislation in terms of animal welfare, being zebrafish-based 
bioassays an alternative to animal experiments and an opportunity to assess the 
environmental risk of xenobiotics in a small-scale (Scholz et al., 2008). The fish embryo 
toxicity test (FET) conducted with this species is one of the most used tests performed 
with zebrafish embryos, and some of its advantages are related to the required small 
amounts of test compounds, short periods of exposure and single breeding stock (OECD, 
2013).  
1.8. Objectives 
The present study aimed to evaluate the effects of the two drugs, SIM and CA, in 
zebrafish larvae and juveniles. To achieve this purpose, an acute (120 hpf) and chronic (60 
dpf) exposures were conducted to a range of concentrations of each pharmaceutical 
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compound, at ecologically relevant concentrations, i.e., concentrations already found in 
the environment. In order to evaluate their toxic effects, behavioral analysis (zebrabox 
testing for the small and large distance traveled, as well as the swimming time and total 
distance) and biochemical markers of oxidative stress (determination of the activity of the 
enzymes SOD, CAT and GPx), biotransformation (GSTs), and lipid peroxidation (TBARS) 
and histological assessment (sex determination and gonadal developmental stages) were 
evaluated.  
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2. MATERIAL AND METHODS 
2.1. Chemicals 
The chemicals used in this study, namely SIM ([(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-
hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-
dimethylbutanoate; CAS: 79902-63-9; purity ≥ 97 %) and CA (2-(p-Chlorophenyl)-2-
methylpropanoic acid; CAS: 882-09-7; purity ≥ 99 %) were acquired from Sigma-Aldrich 
(Schnellforf, Germany). Exposure media were prepared by successive dilution of the stock 
solutions, with water provided from Tecniplast ZebTEC Zebrafish Facility recirculating 
system. Two stock solutions of SIM were prepared in ultrapure water (Milli-Q-Water), one 
with a concentration of 4 mg L-1, which was used to prepare a second stock solution, with 
a concentration of 4 µg L-1. However, only one stock solution of CA was prepared, with a 
concentration of 1,2 mg L-1. Ethyl 3-aminobenzoate methanesulfonate (MS-222; CAS: 886-
86-2), reduced glutathione (GSH; CAS: 70-18-8), 1-chloro-2,4-dinitrobenzene (CDNB; CAS: 
97-00-7), hydrogen peroxide (H2O2; CAS: 7722-84-1), trichloroacetic acid (TCA; CAS: 76-
03-9), 2-thiobarbituric acid (TBA; CAS: 504-17-6), glutathione reductase (GR; CAS: 9001-
48-3), cumene hydroperoxide (CAS: 80-15-9), cytochrome c (CAS: 9007-43-6), potassium 
cyanide (CAS: 151-50-8) and bovine γ-globulin (CAS: 9007-83-4) were purchased from 
Sigma-Aldrich. Bradford reagent was purchased from Bio-Rad UK. The chemicals used for 
histological analyses were ethanol absolute (CAS: 64-17-5), acquired from AGA – Álcool e 
Géneros Alimentares S.A.; Appliclear (Xylene substitute) (CAS: 64742-49-0), Bouin liquor 
for clinical diagnosis, and Histofix decalcifier 1 for clinical diagnosis, all were purchased 
from PanReac AppliChem ITW Reagents; Hematoxylin solution modified acc. to Gill III, 
Certistain (Eosin y) (CAS: 15086-94-9) and DPX new (non-aqueous mounting medium for 
microscopy) were acquired from Merck-Millipore; Hydrochloric acid standard solution 1M 
was purchased from Fluka Analytical (Sigma-Aldrich). All other chemicals for buffers 
preparation were obtained either from Sigma-Aldrich or Merck-Millipore. 
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2.2. Test organisms 
Individuals of the test species (Danio rerio) used in this study were kept in a 
Tecniplast ZebTEC Zebrafish Facility recirculating system under controlled conditions 
(OECD, 2013). Water temperature was 26 ± 1°C, pH was 7.5 ± 0.5, conductivity was 750 ± 
50 µS cm-1, and dissolved oxygen was equal or above 95% of saturation. The culture water 
was tap water filtered and purified by activated carbon and reverse osmosis, to which 
“Instant Ocean Synthetic Sea Salt” (Spectrum Brands, USA) was added to regulate the 
conductivity to 800 µS cm-1. The photoperiod cycle was upheld at 16h:8h (light: dark). The 
adult individuals were fed twice daily during the week, once on the weekend, with an 
artificial diet [GEMMA Micro 500, acquired from Skretting Zebrafish (Maine, United 
States)]. To protect eggs from predation by adult individuals, marbles were placed in the 
bottom of the aquarium for refuge. After the removal of the marbles, eggs were 
collected, rinsed with water and malformations or absence of cleavage were identified 
under a stereomicroscope (Nikon, SMZ 1500) for eggs to be discarded.  
2.3. Concentrations of chemicals 
The concentrations to which test organisms were exposed, in both chronic and 
acute exposures, were 92.45, 184.9, 369.8, 739.6 and 1479.2 ng L-1 for SIM, and 10.35, 
20.7, 41.4, 82.8 and 165.6 μg-1 L for CA. The most concentrated solution of each 
contaminant was directly prepared from the stock solution, and submitted to successive 
dilution, as mentioned before. The intermediate concentration values for each of the 
contaminants (SIM – 369.8 ng L-1; CA – 41.4 µg L-1) were based on ecologically relevant 
concentrations, i.e., the maximum level found in effluents from wastewater treatment 
plants in Portugal (Salgado et al., 2010) and in the predicted environmental 
concentrations for Portuguese surface waters (Pereira et al., 2015), as well as the levels 
found in WWTP influents (11.7±3.2 µg L-1), effluents (2.65±0.8 µg L-1) and Apies River 
(1.585±0.3 µg L-1), all located in Pretoria, South Africa (Tete et al., 2019), respectively. 
Lower concentrations were thus considered realistic and ecologically relevant; higher 
concentrations allowed testing for the organisms´ responsiveness towards both 
chemicals.  
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2.4. Acute exposure  
The method used in acute exposure was a modified fish embryotoxicity test (FET; 
OECD, 2013). In the present study, eggs were transferred to 96-well plates, each well 
containing 300 μL of each test solution and one egg, five replicates (20 pools, a total of 
100 eggs) for each concentration and control group, for each contaminant. For the 
measurement of the behavioral and biomarker activities, the larvae were exposed during 
120 h, for behavioral assessment and subsequent biochemical analysis.  
CA has a half-life of 50 h in natural water irradiated by sunlight (Packer et al., 
2003). Therefore, every two days (approximately 48h), exposure media for both 
contaminants were newly made, with water retrieved from the Tecniplast ZebTEC 
Zebrafish Facility recirculating system, including control group, and partially renewed by 
approximately 80%, according to the OECD guidelines (OECD, 1984; OECD, 1992; OECD, 
2011; OECD, 2013). 
2.4.1. Behavioral test  
The period of exposure to both drugs was extended to 120 hpf, as mentioned 
before, to allow the complete development of the swim bladder. Only then it was 
possible to evaluate locomotor activity using the Zebrabox (Viewpoint, Lyon, France) 
tracking system under stabilized temperature (26±1 °C). The larvae were observed for the 
identification of morphological alterations or deformations that could compromise 
locomotory capacity, being removed from the test if such conditions were observed 
(Şişman et al., 2008). The test was conducted in a cycle of four alternating periods during 
twenty minutes, i.e., 1200 s [0 to 300 s (light), 300 to 600 s (dark), 600 to 900 s (light), 900 
to 1200 s (dark)]. The alternate light and dark cycles are justified by the natural behavior 
of D. rerio; normally developing larvae show little to no movement in the light periods 
and increase their swimming activity in dark periods (Collier et al., 2017). Data outputs 
were obtained at the end of each cycle and the following parameters were calculated: 
relatively small (less than 0.5 mm s-1) and large distance, total distance traveled (sum of 
small and large distance traveled) and relative swimming time.  
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After the motor activity test, pools of 20 larvae (as mentioned before) were 
allocated into Eppendorf microtubes and kept at -80 °C. For the biomarker analysis, the 
larvae were homogenized in 1 mL of phosphate buffer (50 mM, pH = 7.0, with Triton X-
100 0.1 %) by sonication (Branson S-250A), on ice, during 30 seconds, and centrifuged 
(refrigerated centrifuge Thermo Fisher Scientific - Heraeus mod. Megafuge 8R) at 15.000 
g during 10 min at 4°C. After centrifugation, the remaining pellets were discarded, and 
the supernatants were collected and stored at -80 °C.  
2.4.2. Biochemical analyses 
2.4.2.1. Superoxide dismutase activity quantification 
The SOD activity quantification (total, Cu-ZnSOD, and MnSOD) was based on the 
method described by Flohé & Ötting (1984). A xanthine-xanthine oxidase system 
produced superoxide radicals. The result of the reaction of these radicals with 
cytochrome c represented SOD’s total activity. Potassium cyanide inhibited the activity of 
Cu-ZnSOD, allowing the quantification of the isolated activity of MnSOD. Thus, results for 
Cu-ZnSOD were obtained as the difference between total SOD activity and MnSOD 
activity, being compared with MnSOD activity. The enzymatic activity in all of these cases 
was spectrophotometrically followed at λ = 550 nm and was then expressed in mmol min-
1 mg-1 of protein. 
2.4.2.2. Catalase activity quantification  
CAT activity quantification was based on the protocol by Aebi (1984). The 
decomposition of H2O2 was catalyzed by CAT. This decomposition was 
spectrophotometrically followed at λ = 240 nm, by the decrease of absorbance. The 
enzymatic activity was then expressed in μmol min-1 mg-1 of protein.  
2.4.2.3. Glutathione peroxidase activity quantification 
The GPx activity quantification was based on the method proposed by Flohé & 
Günzler (1984). The reduction of oxidized L-glutathione (GSSG) to its reduced form, GSH, 
by glutathione reductase, through the oxidation of NADPH (ε = 6.2 mM cm-1), was 
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spectrophotometrically followed at λ = 340 nm. GPx selenium-dependent activity was 
measured using H2O2 as a substrate, whereas GPx total activity (selenium-dependent + 
non-dependent) was measured using cumene hydroperoxide as a substrate. The 
enzymatic activity was then expressed in mmol min-1 mg-1 of protein. 
2.4.2.4. Glutathione S-transferases activity quantification  
GSTs activity quantification was based on the method described by Habig et al. 
(1974). The conjugation of CDNB with GSH was catalyzed by GSTs, which led to the 
formation of a thioether (ε = 9.6 mM cm-1). This formation was spectrophotometrically 
followed at λ = 340 nm, by the increase of the absorbance. The enzymatic activity was 
then expressed in μmol min-1 mg-1 of protein.  
2.4.2.5. Thiobarbituric acid reactive substances quantification 
The TBARS quantification was based on the protocol described by Buege & Aust 
(1978). In the presence of thiobarbituric acid (TBA) and heat (water bath at approximately 
100 °C), malondialdehyde (MDA)-like compounds reacted with TBA, which led to the 
formation of a colored end product. This formation was spectrophotometrically 
quantified at λ = 535 nm. TBARS concentrations, expressed as MDA equivalents, were 
then calculated in μmol min-1 mg-1 of protein.  
2.4.2.6. Protein determination  
The quantification of protein of all the samples was based on the protocol by 
Bradford (1976). The conjugation of the Bradford reagent with the total protein led to the 
formation of a colored and stable complex, which was spectrophotometrically measured 
at λ = 595 nm. Protein standards were prepared with bovine γ-globulin in a concentration 
of 1 mg mL-1.  
2.5. Chronic exposure 
Chronic exposure was based on OECD guidelines (OECD, 2011; OECD, 2013), with 
some modifications. In the present study, seven hundred and twenty eggs were 
transferred into twenty-four Petri dishes (with 15 mL of exposure medium each), twenty-
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five eggs per plate, at the beginning of the experiment. At 96 hpf, larvae were transferred 
into the exposure aquariums (1 L each). Twenty-five larvae were assigned per aquarium, 
two replicates for each concentration, including a control group (unexposed individuals), 
for each contaminant. The aquaria were randomly distributed in the exposure room, 
under wide spectrum fluorescent bulbs. 
The exposure period ended at 60 dpf (chronic exposure) according to the OECD 
guideline (OECD, 2011). Fish were fed twice daily during the week, and once during the 
weekend, with synthetic rations, particularly GEMMA Micro 150 (9 to 30 dpf), GEMMA 
Micro 300 (30 to 60 dpf), acquired from Skretting Zebrafish (Maine, United States), 
according to Martins et al. (2016).  
The exposure media for both contaminants was partially renewed by 
approximately 80%, according to the OECD guidelines and as mentioned before for the 
acute exposure, i.e., each 48 hours (OECD, 2011; OECD, 2013). 
The water used to prepare the exposure media was under controlled conditions 
(water temperature = 26 ± 1°C, pH = 7.5 ± 0.5, conductivity = 750 ± 50 µS cm-1 and 
dissolved oxygen saturation ≥ 95%). During the exposure, mortality was below 70% in all 
treatment groups, with no mortality in the control group, in agreement with the 
requirements of the adopted OECD guideline (OECD, 2011). 
2.5.1. Fish sacrifice 
After the chronic exposure, five specimens from each aquarium were euthanized 
by immersion into a solution of MS-222 (250 mg L-1), according to the OECD guideline 
(OECD, 2011) until there was no observable opercular movement and the specimens 
could not swim. Experiments took into consideration the AVMA Guidelines for the 
euthanasia of animals and the Portuguese animal welfare law (Decreto-Lei 113/2013). 
This facility is certified by the Portuguese veterinarian authority and the experiments 
were conducted according to guidelines set up by the animal welfare commission of the 
University of Aveiro. 
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2.5.2. Sample processing 
Fish were dissected, the head and tail were removed and discarded, for the 
incorporation of Bouin solution into the entire organism, and the specimens (five per 
replicate) were held in plastic tissue cassettes, followed by immersion into Bouin solution 
for 24h. After chemically fixed in Bouin, the specimens in tissue cassettes were decalcified 
(24h), dehydrated through an increasing series of alcohols (70 %, 80 %, 90 % and 100 %, 
one hour each), cleared with xylene (2 h), impregnated in paraffin wax (56 to 58 °C), and 
sectioned (5 to 7 µm) using a microtome (Leica, Reichert-Jung 2030). These sections were 
stained with hematoxylin-eosin, mounted with DPX in coverslips, and analyzed by light 
microscopy (Olympus CX41) for the sex determination and identification of the gonadal 
developmental stages, according to Brown‐Peterson et al. (2011). Female individuals 
were classified, such as immature (only oogonia and primary growth oocytes present), 
early developing subphase (only primary growth and cortical alveolar oocytes present), 
developing (primary growth, cortical alveolar, primary vitellogenic and secondary 
vitellogenic oocytes present), spawning capable (tertiary vitellogenic oocytes or 
postovulatory follicle complex present), regressing and regenerating. Male individuals 
were classified as immature (only primary spermatogonia present), early developing 
subphase (only primary spermatogonia, secondary spermatogonia, and primary 
spermatocyte present), developing (secondary spermatogonia, primary spermatocyte, 
secondary spermatocyte, spermatids and spermatozoa present), spawning capable 
(spermatozoa in lumen; the various stages of spermatogenesis can be present), regressing 
and regenerating (Brown-Peterson et al., 2011).  
2.6. Statistical analyses  
Data from behavioral and biochemical testing was evaluated for equal variance 
(Levene test) and normality (Shapiro-Wil test) prior to the statistical analyses, with 
attempted transformations to the data, when needed. Behavioral results were compared 
by a One-way ANOVA on Ranks, and in some cases by a One-Way ANOVA, when data 
transformations made it possible. On the other hand, biochemical results were only 
compared by or One-way ANOVA (Murphy et al., 2003). These statistical analyses were 
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followed by a Dunnett or Dunn multi-comparison test, after One-way ANOVA or One-way 
ANOVA on Ranks, respectively, to identify significant differences between the treatments 
and the control group. Data from sex determination was evaluated statistically for 
homogeneity with the heterogeneity chi-square analysis, whereas gonadal developmental 
stages were also statistically evaluated for homogeneity and independence of occurrence 
through a G test, according to Zar (2010). The adopted level of significance for all 
statistical methods was 0.05. Data are presented as mean and standard error. The 
analyses were performed with the software SPSS 24.0. 
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3. RESULTS 
3.1. Simvastatin  
3.1.1. Acute exposure 
3.1.1.1. Behavioral results 
According to the results obtained in terms of small distance traveled by fish 
exposed to SIM (Figure 3), there were significant differences between treated groups and 
the control animals, in all light and dark periods. During the first light cycle (0 to 300s), 
there was a significant decrease in the small distance travelled, except for the organisms 
exposed to the second highest concentration (739.6 ng L-1), compared with control 
treatment (One-Way ANOVA on Ranks followed by a Dunn’s test: H5=91.651, p<0.001). 
During the first dark period (300 to 600s), there was a significant increase, particularly in 
animals exposed to the intermediate (369.8 ng L-1) and highest concentrations (1479.2 ng 
L-1), compared with control (One-Way ANOVA on Ranks followed by a Dunn’s test: 
H5=67.317, p<0.001). During the second light cycle (600 to 900s), there was a significant 
decrease in fish exposed to the lowest concentration (92.45 ng L-1), followed by a 
significant increase in those exposed to the highest concentration (1479.2 ng L-1), 
comparing to the control (One-Way ANOVA on Ranks followed by a Dunn’s test: H5=35.1, 
p<0.001). In the final dark period (900 to 1200s), there was a significant decrease, namely 
in animals exposed to the lowest (92.45 ng L-1) and second highest concentrations (739.6 
ng L-1), followed by a significant increase in individuals subjected to the highest 
concentration (1479.2 ng L-1), compared with control (One-Way ANOVA on Ranks 
followed by a Dunn’s test: H5=101.299, p<0.001).  
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Figure 3 - Small distance traveled for individuals exposed to SIM, in cycles of light and dark 
periods. Data are Mean±SE (n=20 fish/treatment). Stands for light cycles while 
stands for dark periods. * Stands for significant differences among treatments, compared with the 
control, during the respective light or dark period (Dunn’s test, p<0.05). 
 
Considering the large distance traveled by fish exposed to SIM, there were 
significant differences between the treatment groups and the control fish, for all the light 
and dark periods (Figure 4). During the first light cycle (0 to 300s), there was a significant 
increase, except for the organisms exposed to the lowest (92.45 ng L-1) and highest 
(1479.2 ng L-1) concentrations, compared with control (One-way ANOVA followed by a 
Dunnett’s test: H5=111.148, p<0.001). During the first dark period (300 to 600s), there 
was a significant decrease in the individuals subjected to the lowest concentration (92.45 
ng L-1), followed by a significant increase in those exposed to the second highest 
concentration (739.6 ng L-1), compared with control (One-Way ANOVA on Ranks followed 
by a Dunn’s test: H5= 59.682, p<0.001). During the second light cycle (600 to 900s), there 
was a significant decrease in organisms exposed to the lowest concentration (92.45 ng L-
1), followed by a significant increase in those subjected to the two highest concentrations 
(739.6 and 1479.2 ng L-1), compared with control (One-Way ANOVA on Ranks followed by 
a Dunn’s test: H5=86.617, p<0.001). In the final dark period (900 to 1200s), there was a 
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significant increase in individuals exposed to the three highest concentrations (369.8, 
739.6 and 1479.2 ng L-1), compared with control (One-Way ANOVA on Ranks followed by 
a Dunn’s test: H5=61.514, p<0.001). 
 
Figure 4 - Large distance traveled for individuals exposed to SIM, in cycles of light and dark 
periods. Data are Mean±SE (n=20 fish/treatment). Stands for light cycles while 
stands for dark periods. * Stands for significant differences among treatments, compared with 
control, during the respective light or dark period (Dunnett’s test in the first light cycle and Dunn’s 
test in the other periods, p<0.05). 
 
According to the results of swimming time measured in fish exposed to SIM, there 
were significant differences between treatment groups and the control, in the light and 
dark cycles (Figure 5). During the first light cycle (0 to 300s), there was a significant 
decrease in organisms exposed to the intermediate (369.8 ng L-1) and second highest 
concentration (739.6 ng L-1), compared with control (One-Way ANOVA on Ranks followed 
by a Dunn’s test: H5=18.426, p=0.002). During the first dark period (300 to 600s), there 
was a significant decrease in the organisms exposed to the two lowest concentrations 
(92.45 and 184.9 ng L-1), followed by a significant increase in the two highest 
concentrations (739.6 and 1479.2 ng L-1), compared with control (One-Way ANOVA on 
Ranks followed by a Dunn’s test: H5=99.196, p<0.001). During the second light cycle (600 
to 900s), no significant differences were found between animals from the treatment 
groups and from the control. In the final dark cycle (900 to 1200s), there was a significant 
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decrease in individuals exposed to the lowest concentration (92.45 ng L-1), followed by a 
significant increase in those subjected to the two highest concentrations (739.6 and 
1479.2 ng L-1), compared with control (One-Way ANOVA on Ranks followed by a Dunn’s 
test: H5=92.713, p<0.001). 
 
Figure 5 - Swimming time for individuals exposed to SIM, in cycles of light and dark periods. Data 
are Mean±SE (n=20 fish/treatment). Stands for light cycles while stands for 
dark periods. * Stands for significant differences among treatments, compared with control, 
during the respective light or dark period (Dunn’s test, p<0.05). 
 
Considering the total distance traveled by fish exposed to SIM, there were 
significant differences found between the treatments and the control group in all the light 
and dark periods (Figure 6). During the first light cycle (0 to 300s), there was a significant 
increase, particularly in the individuals exposed to the lowest (92.45 ng L-1), intermediate 
(369.8 ng L-1) and second highest concentration (739.6 ng L-1), compared with control 
(One-Way ANOVA on Ranks followed by a Dunn’s test: H5=57.018, p<0.001). During the 
first dark period (300 to 600s), there was a significant decrease in the organisms exposed 
to the lowest concentration (92.45 ng L-1), followed by a significant increase in those 
exposed to the two highest concentrations (739.6 and 1479.2 ng L-1), compared with 
control (One-Way ANOVA on Ranks followed by a Dunn’s test: H5=82.244, p<0.001). 
During the second light cycle (600 to 900s), there was a significant decrease in the 
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individuals exposed to the lowest concentration (92.45 ng L-1), followed by a significant 
increase in those exposed to the second highest concentration (739.6 ng L-1), compared 
with control (One-Way ANOVA on Ranks followed by a Dunn’s test: H5=75.903, p<0.001). 
During the second and final dark period (900 to 1200s), there was a significant increase in 
the organisms exposed to the two highest concentrations (739.6 and 1479.2 ng L-1), 
compared with control (One-Way ANOVA on Ranks followed by a Dunn’s test: H5=60.931, 
p<0.001). 
 
 
 
 
3.1.1.2. Biochemical results 
3.1.1.2.1. Superoxide dismutase 
 According to the results obtained in terms of copper-zinc SOD (Cu-ZnSOD) activity 
in fish exposed to SIM, there was a significant decrease, except for the individuals 
exposed to the lowest concentration (92.45 ng L-1), compared with control (One-way 
ANOVA followed by a Dunnett’s test: F5.15=37.728, p<0.001). Manganese SOD (MnSOD) 
Figure 6 - Total distance traveled for individuals exposed to SIM, in cycles of light and dark periods. 
Data are Mean±SE (n=20 fish/treatment).        Stands for light cycles while          stands for dark 
periods. * Stands for significant differences among treatments, compared with the control, during 
the respective light or dark period (Dunn’s test, p<0.05). 
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activity in the same individuals revealed no significant differences between treatment 
groups and the control (Figure 7).  
 
Figure 7 – Cu-ZnSOD activity (grey) and MnSOD activity (black) in individuals exposed to SIM. Data 
are Mean±SE (n=20 fish/treatment). * Stands for significant differences among treatments, 
compared with control, in each SOD activity (Cu-Zn or Mn) (Dunnett’s test, p<0.05). 
3.1.1.2.2. Catalase 
Considering the results obtained in terms of the CAT activity in fish exposed to 
SIM, there were no significant differences found between the treatment groups and the 
control animals (One-way ANOVA: F5.12=3.784, p=0.027) (Figure 8). 
 
0
2
4
6
8
10
12
14
16
0 92.45 184.9 369.8 739.6 1479.2
C
A
T
 a
c
ti
v
it
y
(µ
m
o
l 
m
in
-1
m
g
-1
p
ro
te
in
)
Simvastatin concentration (ng L-1)
 
Figure 8 - CAT activity in individuals exposed to SIM. Data are Mean±SE (n=20 fish/treatment).  
32 
 
3.1.1.2.3. Glutathione peroxidase 
According to the results of GPx total activity in fish exposed to SIM, there was a 
significant decrease, except for animals subjected to the lowest concentration (92.45 ng L-
1), compared with control (One-way ANOVA followed by a Dunnett’s test: F5.15=8.567, 
p<0.001). GPx selenium-dependent activity reported a significant increase in organisms 
exposed to the lowest concentration (92.45 µg L-1), compared with control (One-way 
ANOVA followed by a Dunnett’s test: F5.13=16.685, p<0.001) (Figure 9). 
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Figure 9 - GPx total activity (black) and selenium-dependent activity (grey) in individuals exposed 
to SIM. Data are Mean±SE (n=20 fish/treatment). * Stands for significant differences among 
treatments, compared with control, in each GPx activity (total or selenium-dependent) (Dunnett’s 
test, p<0.05). 
3.1.1.2.4. Glutathione S-transferases 
Considering the GSTs activity of fish exposed to SIM, there was a significant 
decrease in animals of all the treatment groups, compared with control (One-way ANOVA 
followed by a Dunnett’s test: F5.18=17.955, p<0.001) (Figure 10). 
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Figure 10 – GSTs activity in individuals exposed to SIM. Data are Mean±SE (n=20 fish/treatment). * 
Stands for significant differences among treatments, compared with control (Dunnett’s test, 
p<0.05). 
3.1.1.2.5. Thiobarbituric acid reactive substances 
The results obtained in terms of TBARS in fish exposed to SIM, evidenced a 
significant decrease, except for the individuals subjected to the lowest concentration 
(92.45 ng L-1), compared with control (One-way ANOVA followed by a Dunnett’s test: 
F5.13=12.107, p<0.001) (Figure 11). 
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Figure 11 - TBARS in individuals exposed to SIM. Data are Mean±SE (n=20 fish/treatment). * 
Stands for significant differences among treatments, compared with control (Dunnett’s test, 
p<0.05). 
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3.1.2. Chronic exposure 
3.1.2.1. Sex determination 
Taking into consideration the visual inspection of the HE glass slides of gonads, 
and after appropriate statistical treatment, no significant differences were found, in 
terms of sex determination (i.e. the percentage of males vs females) of the individuals 
exposed to SIM (χ2=7.433, df=5, p=0.190) (Figure 12).  
 
0
10
20
30
40
50
60
70
80
90
100
0 92.45 184.9 369.8 739.6 1479.2
S
e
x
 r
a
ti
o
 
(%
 m
a
le
s
 a
n
d
 f
e
m
a
le
s
) 
Simvastatin concentration (ng L-1)
Females
Males
 
Figure 12 – Sex ratio (percentage of males and females) in individuals exposed to SIM (n=10 
fish/treatment). 
3.1.2.2. Gonadal developmental stages 
Only four of the six stages of maturation were identified in females exposed to 
SIM, namely immature phase, early developing subphase, developing phase and 
spawning capable phase (Figure 13).  
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Figure 13 – Histological architecture in terms of maturation stages of females in different 
treatment groups exposed to SIM (n=10 fish/treatment). (A) Immature phase at 1479.2 ng L-1, 
with primary growth oocytes (arrow) (200x); (B) Early developing subphase at 184.9 ng L-1, with 
cortical alveolar oocyte (arrow) (200x); (C) Developing phase at 92.45 ng L-1, with primary 
vitellogenic oocyte (arrowhead) and secondary vitellogenic oocyte (arrow) (200x); and (D) 
Spawning capable phase at 92.45 ng L-1, with tertiary vitellogenic oocyte (arrow) (200x). 
 
Regarding the recorded developmental stages, no significant differences were 
found among groups (G=1.913, df=15, p=0.999) (Figure 14). 
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Figure 14 – Female developmental stage in individuals exposed to SIM (n=10 fish/treatment).  
 
Only four of the six stages of maturation of spermatocytes were identified in 
males exposed to SIM, namely immature phase, early developing subphase, developing 
phase and spawning capable phase (Figure 15). 
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Figure 15 – Histological architecture in terms of maturation stages of spermatocytes identified in 
different treatment groups exposed to SIM (n=10 fish/treatment). (A) Immature phase at 369.8 ng 
L-1, with primary spermatogonia (arrow) (400x); (B) Early developing subphase at 184.9 ng L-1, 
with primary spermatocyte (arrow) (400x); (C) Developing phase at 369.8 ng L-1, with secondary 
spermatocyte (arrow) (400x); and (D) Spawning capable phase in the control group, with 
spermatids (arrowhead) and spermatozoa (arrow) (400x). 
 
 
Taking into consideration the observation of male developmental stages in 
individuals exposed to SIM, no significant differences were found (G=1.401, df=15, 
p=0.999) (Figure 16). 
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Figure 16 – Male developmental stage in individuals exposed to SIM (n=10 fish/treatment). 
3.2. Clofibric acid 
3.2.1. Acute exposure 
3.2.1.1. Behavioral results 
According to the results for small distance traveled by fish exposed to CA, there 
were significant differences between treatment groups and the control in all of the light 
and dark periods (Figure 17). During the first light cycle (0 to 300s), there was a significant 
decrease in organisms exposed to the three lowest concentrations (10.35, 20.7 and 41.4 
µg L-1), followed by a significant increase in fish subjected to the highest concentration, 
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compared with control (One-Way ANOVA on Ranks followed by a Dunn’s test: 
H5=159.151, p<0.001). During the first dark period (300 to 600s), there was a significant 
decrease in organisms exposed to second lowest (20.7 µg L-1) and the intermediate 
concentration (41.4 µg L-1), also followed by a significant increase, namely in those 
subjected to the two highest concentrations (82.8 and 165.6 µg L-1), compared with 
control (One-Way ANOVA on Ranks followed by a Dunn’s test: H5=249.941, p<0.001). The 
second light cycle (600 to 900s) followed the pattern of the first light cycle, with a 
significant decrease in organisms exposed to the three lowest concentrations (10.35, 20.7 
and 41.4 µg L-1), followed by a significant increase in fish subjected to the highest 
concentration, compared with control (One-Way ANOVA on Ranks followed by a Dunn’s 
test: H5=95.409, p<0.001). Finally, in the last dark cycle (900 to 1200s), there was a 
significant decrease in the individuals exposed to the first three treatment groups, 
compared with the control group (One-Way ANOVA on Ranks followed by a Dunn’s test: 
H5=234.994, p<0.001).  
 
Figure 17 - Small distance traveled for individuals exposed to clofibric acid, in cycles of light and 
dark periods. Data are Mean±SE (n=20 fish/treatment). Stands for light cycles while 
stands for dark periods. * Stands for significant differences among treatments, compared with the 
control, during the respective light or dark period (Dunn’s test, p<0.05). 
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Considering the results for large distance traveled by fish exposed to CA, there 
were significant differences between treatment groups and the control for all the light 
and dark periods (Figure 18). During the first light cycle (0 to 300s), there was a significant 
decrease in the large distance travelled in all treatment groups, except for organisms 
exposed to the second lowest concentration (20.7 µg L-1), compared with control (One-
Way ANOVA on Ranks followed by a Dunn’s test: H5=120.544, p<0.001). During the first 
dark period (300 to 600s), there was also a significant decrease in all treatment groups, 
except for individuals subjected to the highest concentration (165.6 µg L-1), compared 
with control (One-Way ANOVA on Ranks followed by a Dunn’s test: H5=152.207, p<0.001). 
During the second light cycle (600 to 900s), there was also a significant decrease in all 
treatment groups, except for organisms exposed to the lowest concentration (10.35 µg L-
1), compared with control (One-Way ANOVA on Ranks followed by a Dunn’s test: 
H5=104.041, p<0.001). Finally, during the second dark period (900 to 1200s), there was a 
significant decrease in all treatment groups, compared with control, through a directly 
proportional increase between treatments, according to the concentration (One-way 
ANOVA followed by a Dunnett’s test: F5.251=46.171, p<0.001). 
 
Figure 18 - Large distance traveled for individuals exposed to clofibric acid, in cycles of light and 
dark periods. Data are Mean±SE (n=20 fish/treatment). Stands for light cycles while 
stands for dark periods. * Stands for significant differences among treatments, compared with the 
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control, during the respective light or dark period (Dunn’s test in the three first periods, and 
Dunnett’s test in the last dark cycle, p<0.05). 
According to the swimming time of fish exposed to CA, there were significant 
differences between treatment groups and the control, in the dark and light periods 
(Figure 19). During the first light cycle (0 to 300s), no significant differences were found 
between treatment groups and the control. During the first dark period (300 to 600s), 
there was a significant decrease between some of the treatment groups and the control, 
except for organisms exposed to the intermediate (41.4 µg L-1) and the highest 
concentration (165.6 µg L-1) (One-Way ANOVA on Ranks followed by a Dunn’s test: 
H5=118.803, p<0.001). For the second light cycle (600 to 900s), there was a significant 
decrease in organisms exposed to the lowest concentration (10.35 µg L-1) and a significant 
increase in those subjected to the highest concentration (165.6 µg L-1), following a 
directly proportional pattern of swimming time and concentration, compared with 
control (One-Way ANOVA on Ranks followed by a Dunn’s test: H5=57.447, p<0.001). For 
the final dark period (900 to 1200s), there was only a significant decrease in individuals 
exposed to the lowest concentration (10.35 µg L-1), compared with control (One-Way 
ANOVA on Ranks followed by a Dunn’s test: H5=91.117, p<0.001). 
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Figure 19 – Swimming time for individuals exposed to CA, in cycles of light and dark periods. Data 
are Mean±SE (n=20 fish/treatment). Stands for light cycles while stands for dark 
periods. * Stands for significant differences among treatments, compared with control, during the 
respective light or dark period (Dunn’s test, p<0.05). 
 
Considering the total distance traveled by fish exposed to CA, there were 
significant differences between fish from all treatment groups and the control treatment, 
in all the light and dark periods (Figure 20). During the first light cycle (0 to 300s), there 
was a significant decrease in all treatment groups, compared with control (One-Way 
ANOVA on Ranks followed by a Dunn’s test: H5=99.626, p<0.001). During the first dark 
period (300 to 600s), there was also a significant decrease, except for organisms exposed 
to the highest concentration (165.6 µg L-1), compared with control (One-Way ANOVA on 
Ranks followed by a Dunn’s test: H5=172.918, p<0.001). During the second light cycle (600 
to 900s), there was a significant decrease, except for individuals subjected to the lowest 
concentration (10.35 µg L-1), compared with control (One-Way ANOVA on Ranks followed 
by a Dunn’s test: H5=53.170, p<0.001). During the second and final dark period (900 to 
1200s), the pattern was similar to the first dark cycle, with a significant decrease, except 
for organisms exposed to the highest concentration (165.6 µg L-1), compared with control 
(One-Way ANOVA on Ranks followed by a Dunn’s test: H5=163.561, p<0.001). 
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Figure 20 – Total distance traveled for individuals exposed to CA, in cycles of light and dark 
periods. Data are Mean±SE (n=20 fish/treatment). Stands for light cycles while 
stands for dark periods. * Stands for significant differences among treatments, compared with 
control, during the respective light or dark period (Dunn’s test, p<0.05). 
3.2.1.2. Biochemical results 
3.2.1.2.1. Superoxide dismutase 
Considering the results obtained for Cu-ZnSOD activity in fish exposed to CA, there 
was a significant increase, namely in animals subjected to the two highest concentrations 
(82.8 and 165.6 µg L-1), compared with control (One-way ANOVA followed by a Dunnett’s 
test: F5.12=308.926, p<0.001). MnSOD activity in the same individuals showed a significant 
increase, particularly in fish from the intermediate (41.4 µg L-1) and highest 
concentrations (165.6 µg L-1), compared with control (One-way ANOVA followed by a 
Dunnett’s test: F5.13=12.917, p<0.001) (Figure 21). 
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Figure 21 – Cu-ZnSOD activity (grey) and MnSOD activity (black) in individuals exposed to CA. Data 
are Mean±SE (n=20 fish/treatment). * Stands for significant differences among treatments, 
compared with control, in each SOD activity (Cu-Zn or Mn) (Dunnett’s test, p<0.05). 
3.2.1.2.2. Catalase 
Considering the CAT activity in fish exposed to CA, there was a significant increase 
for animals exposed to the second lowest concentration (20.7 µg L-1), followed by a 
significant decrease in fish exposed to the highest concentration (165.6 µg L-1) (One-way 
ANOVA followed by a Dunnett’s test: F5.17=11.657, p<0.001) (Figure 22). 
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Figure 22 - CAT activity in individuals exposed to CA. Data are Mean±SE (n=20 fish/treatment). * 
Stands for significant differences among treatments, compared with control (Dunnett’s test, 
p<0.05). 
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3.2.1.2.3. Glutathione peroxidase 
Considering the total GPx activity in fish exposed to CA, there was a significant 
increase for animals exposed to the intermediate concentration (41.4 µg L-1), compared 
with control (One-way ANOVA followed by a Dunnett’s test: F5.13=8.123, p=0.001). 
Considering the selenium-dependent GPx activity, there was a significant increase in 
organisms subjected to the intermediate (41.4 µg L-1) and highest concentrations (165.6 
µg L-1), compared with control (One-way ANOVA followed by a Dunnett’s test: F5.14=7.507, 
p=0.001) (Figure 23). 
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Figure 23 – Total (black) and selenium-dependent (grey) GPx activity in individuals exposed to CA. 
Data are Mean±SE (n=20 fish/treatment). * Stands for significant differences among treatments, 
compared with control, in each GPx activity (total or selenium-dependent) (Dunnett’s test, p<0.05). 
3.2.1.2.4. Glutathione S-transferases 
In terms of the GSTs activity obtained in fish exposed to CA, there was a significant 
increase for animals exposed to the second lowest (20.7 µg L-1) and intermediate 
concentrations (41.4 µg L-1), followed by a significant decrease reported in fish exposed to 
the highest concentration (165.6 µg L-1), compared with control (One-way ANOVA 
followed by a Dunnett’s test: F5.13=27.634, p<0.001) (Figure 24).  
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Figure 24 - GSTs activity in individuals exposed to CA. Data are Mean±SE (n=20 fish/treatment). * 
Stands for significant differences among treatments, compared with control (Dunnett’s test, 
p<0.05). 
3.2.1.2.5. Thiobarbituric acid reactive substances 
Considering the TBARS in fish exposed to CA, there was a significant increase in 
animals exposed to the intermediate (41.4 µg L-1) and highest concentrations (165.6 µg L-
1) compared with control (One-way ANOVA followed by a Dunnett’s test: F5.14=11.036, 
p<0.001) (Figure 25). 
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Figure 25 – TBARS in individuals exposed to CA. Data are Mean±SE (n=20 fish/treatment). * Stands 
for significant differences among treatments, compared with control (Dunnett’s test, p<0.05). 
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3.2.2. Chronic exposure 
3.2.2.1. Sex determination 
Taking into consideration the visual inspection of the HE glass slides of gonadal 
tissue, and following appropriate statistical treatment, no significant differences were 
found between individuals exposed to CA, in terms of sex determination (χ2=7.204, df=5, 
p=0.206) (Figure 26). 
 
 
Figure 26 – Sex ratio (percentage of males and females) in individuals exposed to CA (n=20 
fish/treatment). 
3.2.2.2. Gonadal developmental stages 
Only four of the six stages of maturation were identified in females exposed to CA, 
namely immature phase, early developing subphase, developing phase and spawning 
capable phase (Figure 27). 
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Figure 27 – Histological architecture in terms of maturation stages of females in different 
treatment groups exposed to CA (n=10 fish/treatment). (A) Immature phase at 165.6 µg L-1, with 
primary growth oocytes (arrow) (200x); (B) Early developing subphase in the control group, with 
cortical alveolar oocyte (arrow) (200x); (C) Developing phase at 10.35 µg L-1, with primary 
vitellogenic oocyte (arrow) (200x); and (D) Spawning capable phase at 10.35 µg L-1, with tertiary 
vitellogenic oocyte (arrow) (200x). 
 
Moreover, for individuals exposed to CA, no significant differences were found, in 
terms of maturation stages (G=0.662, df=15, p=1) (Figure 28). 
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Figure 28 – Female developmental stage in individuals exposed to CA (n=10 fish/treatment). 
 
Only two of the six stages of maturation were identified in males exposed to CA, 
namely the developing phase and spawning capable phase (Figure 29). 
 
Figure 29 – Histological architecture in terms of maturation stages of spermatocytes identified in 
different treatment groups exposed to CA (n=10 fish/treatment). (A) Developing phase at 20.7 µg 
L-1, with primary spermatocyte (arrowhead) and secondary spermatocyte (arrow) (400x); and (B) 
Spawning capable phase in the control group, with spermatids (arrowhead) and spermatozoa 
(arrow) (400x). 
 
Taking into consideration the observation of male developmental stages in 
individuals exposed to CA, no significant differences were found, in terms of maturation 
stages (G=0.753, df=5, p=0.979) (Figure 30). 
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Figure 30 – Male developmental stage in individuals exposed to CA (n=10 fish/treatment). 
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 4. DISCUSSION 
4.1. Simvastatin 
4.1.1. Behavioral assessment 
To our knowledge, there are no previous data from the literature regarding the 
effects of simvastatin in locomotor ability in early life stages of zebrafish in response to 
stimulation in light-dark transition. 
According to the results obtained for small distance traveled, in individuals 
exposed to SIM, the general patterns observed were a decrease in the first light period, 
an increase in the first dark cycle, and a decrease in the second light and dark periods, 
compared with the control group. Regarding the results obtained in terms of large 
distance traveled in individuals exposed to SIM, the overall patterns reported were an 
increase in the first light period, a decrease in the first dark cycle and an increase in the 
second light and dark periods, compared with control organisms. Overall, small and large 
distance traveled seem to have a proportionally inverse relation. Generally, small distance 
traveled (or small movements) decreased in individuals exposed to SIM, compared with 
control, while large distance traveled increased.  
According to the results obtained for swimming time in individuals exposed to 
SIM, the general patterns observed were a decrease in the first light cycle, an increase in 
the first dark period, relatively similar values in the second light cycle and an increase in 
the second dark period, compared with control.   
Regarding the results of total distance traveled in individuals exposed to SIM, the 
overall pattern reported was an increase in the first light and dark cycles, relatively similar 
values in the second light period, and an increase in the second dark cycle, compared with 
the control group. 
Overall, there was a decrease in erratic movements (small distance) and an 
increase in the traveled large distance. In terms of swimming time and total distance 
traveled, even though there were significant differences in the organisms exposed to SIM. 
As mentioned before, statins can inhibit HMG-CoA reductase, the rate-limiting 
enzyme in the mevalonic acid pathway (Santos et al., 2016). This pathway produces five-
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carbon building blocks that lead to the formation of isoprenoids, e.g., coenzyme Q10 
(CoQ10). In turn, CoQ10 is responsible for the production of ATP in various organs, that 
require a major demand for energy (Pasha & Moon, 2017). Thus, statins can lead to a 
decrease in the production of CoQ10, consequently leading to a decrease in the input of 
energy used for movement, such as evidenced in the parameter small distance traveled. 
Campos et al. (2016) also reported decreasing movement in zebrafish embryos exposed 
to SIM in the range of 0.3 nM to 10 µM. It was inferred in this assay, that the decrease in 
locomotion can also be due to tissue damage, particularly in muscles (Campos et al., 
2016). It was evidenced by a recent study that, even in low concentrations, SIM can affect 
cytoskeleton and adhesion structures involved in myogenesis, by affecting cholesterol 
withdrawal (Campos et al., 2015). This effect occurs since cholesterol has structural and 
signaling functions in myogenesis. The capacity for the reduction in cholesterol levels by 
the exposure to SIM seems to induce a reduction in the amount of extracellular (laminin) 
and intracellular (vinculin and desmin) components present in the myofibrils, the 
composing subunits of muscles cells, which leads to shortening and thickening of its 
structure. SIM can also induce a reduction in the number of differentiated muscle cells 
(Campos et al., 2015). However, the decrease in small distance and increase in large 
distance in this assay suggest a reduction of anxiety-like behavior. Some pharmaceuticals 
with antioxidant properties, such as SIM, are known to decrease erratic movements of 
individuals, such as in this case, through the reduction of stress and anxiety-like behavior 
(Bouayed, 2011; Hassan et al., 2014; De Carvalho et al., 2019). 
However, individuals showed also an increase in swimming time, as well as 
increased total distance traveled, which means that they spent more time swimming, 
while more distance was traveled. This indicates that simvastatin could have caused an 
increase in the overall activity of the organisms exposed. As mentioned before, 
simvastatin can increase the β-oxidation of fatty acids (Park et al., 2016). The increasing 
degradation of fatty acids leads to a higher input of energy in the individuals, leading to 
more locomotion (Orton & Parker, 1982). The metabolism of fatty acids can influence the 
behaviour of individuals, including fertilization and growth rate in zebrafish (Spence et al., 
2008). Overall, data from behavioural analysis suggests that simvastatin potentiates the 
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locomotion of individuals, leading also to a decrease in erratic movements (small 
distance). 
After 96h and when exposed to alternating light and dark periods, zebrafish larvae 
should present increased movement in the dark and decreased in the light (Maximino et 
al., 2010). However, in this essay, regarding total distance traveled and swimming time, 
the effect was the opposite, i.e., there was a decrease in movement in dark periods, 
compared with light periods (Burgess & Granato, 2007). The maturation of the zebrafish 
larvae blood-brain barrier occurs between 3 dpf and 10 dpf (Fleming et al., 2013). Statins 
have hydrophilic and hydrophobic areas, being classified as amphiphilic drugs (Tsinman et 
al., 2011). The hydrophobic region interacts with membrane phospholipids. On the other 
hand, this type of substance does not require specific transport to cross membranes, 
being soluble in aqueous biological fluids and membranes, diffusing through the 
individual (Fong, 2014). SIM is mostly characterized as a lipophilic statin, which has a 
higher risk of neurological and neurocognitive alterations because of its capacity to cross 
the blood-brain barrier (Fong, 2014). Lipids are vital for brain function, as the decrease in 
serum lipid levels can affect the formation of the myelin sheath, neuronal cell 
membranes, and synapses (McFarland et al., 2014). It has been demonstrated in 
Oreochromis niloticus, that the reduction of cholesterol levels by statins, can affect the 
structure of neural cells and neurochemical processes, by compromising the effectiveness 
of the central serotonergic system, leading to behavioral changes (Aguiar & Giaquinto, 
2018). A feature already described for fish, altering their capacity to distinguish between 
light and dark cycles, can be due to neuronal and metabolic disruption, such as 
mentioned. Overall and considering all the behaviour endpoints determined in this study, 
simvastatin seemed to increase locomotion in the individuals exposed, especially large 
distance traveled, and reduce anxiety like-behaviour (small distance). 
Moreover, there was a discrepancy between the observed effects when animals 
were exposed to lower and higher doses of SIM in terms of behavioral assessment, i.e., in 
fish subjected to lower doses, parameters such as small distance, large distance, and total 
distance traveled, as well as swimming time, were significantly decreased; while in 
animals exposed to higher concentrations, there was an increase, compared with control, 
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of such parameters. Dahl et al. (2006) studied growth-related sublethal endpoints in 
harpacticoid copepods, which can affect the locomotion of individuals. In this study, it 
was suggested that differences between effects in low and high concentrations can be 
due to different ecotoxicological modes of action of SIM, i.e., effects at higher 
concentrations (5 to 16 µg L-1) seem to be related to energy-mediated processes, while 
effects in terms of endocrine disruption seem to affect the individuals in lower 
concentrations (<1.6 µg L-1).  
4.1.2. Biochemical assessment 
As mentioned before, superoxide dismutase (SOD) can have three different forms: 
extracellular, MnSOD in the mitochondria, and Cu-Zn SOD in the cytoplasm (Lumb, 2017). 
It constitutes a primary protection system against ROS, particularly superoxide (O2-), and 
its activity results in the production of H2O2 and molecular oxygen (Hayyan et al., 2016).  
According to the results obtained, there were no significant differences in MnSOD 
activity, while Cu-Zn SOD activity was significantly decreased, except for individuals 
exposed to 92.45 ng L-1, comparing to the control. Cunha et al. (2016) also reported a 
decrease in SOD activity in zebrafish embryos exposed to 5 to 50 µg L-1 SIM. The 
decreasing activity of Cu-Zn SOD can be due to the antioxidant properties and synergism 
of SIM with antioxidants. It has been hypothesized that the mechanisms underlying these 
properties of SIM may be due to the inhibition of oxidant formation (NADPH-oxidase) and 
the increase in bioavailability of nitric oxide that can neutralize radicals (Stoll et al., 2004). 
The increase in antioxidant defenses, reduces significantly the quantity of ROS, leading to 
a decrease in antioxidant enzymes activity (Strzyzewski et al., 2013). Statins can decrease 
the production of superoxide anion through a direct effect on the enzyme’s structure and 
consequently its function, thus reducing SOD activity (Delbosc et al., 2002; Wassmann et 
al., 2001). Decreased SOD activity can also be a response to increased production of H2O2 
and O2-, by autooxidation of excess glucose and nonenzymatic glycation of proteins 
(Aragno et al., 1997). Moreover, hydroxyl radicals and hydrogen peroxide can lead to 
partial inactivation of SOD (Pigeolet et al., 1990). 
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As mentioned before, CAT ensures the removal of hydrogen peroxide from the 
organism (Lumb, 2017). It constitutes an antioxidant defense, located in the peroxisomes, 
by reducing H2O2 and molecular oxygen (Aebi, 1984; Modesto & Martinez, 2010). 
Regarding the results obtained in terms of CAT activity in individuals exposed to SIM, no 
significant differences were found, compared with control. The results from this study are 
not in agreement with previously reported data, where exposure to SIM caused an 
increase in CAT activity, in humans (Kaminsky et al., 2010; Piechota-Polanczyk et al., 
2012). De Sotomayor et al. (2005) suggested that HMG-CoA reductase inhibitors, such as 
SIM, inhibit the gp91 phox-containing NADPH oxidase, which is involved in the generation 
of superoxide anions, and in turn increases CAT activity. In this case, and considering the 
absence of increase of CAT activity, the formation of H2O2 seems not to have been 
favoured by the exposure to SIM, despite previous indications. The antioxidant properties 
of SIM allied to the absence of production of H2O2, related to the inhibition of SOD 
activity, can explain the obtained results (Strzyzewski et al., 2013). The lack of significant 
results in our study can also be due to the duration of exposure used in our assay, 
justifying the contradictions in relation to other studies from the literature, which 
indicated an increase in CAT activity, conducted in humans (De Sotomayor et al., 2005; 
Piechota-Polanczyk et al., 2012). It was also suggested by Federici et al. (2007) that the 
absence of significant differences may be due to the capacity of the here used organism 
to use other antioxidant enzymes to avoid oxidative stress, namely GPx, to counteract 
H2O2 levels. 
As mentioned above, GPx acts in a wider range of substrates when compared to 
CAT, reducing organic peroxides, unlike CAT, and reactive oxygen species originated by 
lipid peroxidation (Cohen & Hochstein, 1963; Flohé, 1985; Tappel, 1984). However, 
selenium-dependent GPx can reduce H2O2, while non-selenium dependent GPx does not 
(Battello, 2016). GPx selenium-dependent converts H2O2 and reduced glutathione into 
water and oxidized glutathione (Blondet et al., 2018). 
According to the results obtained in individuals exposed to SIM, in terms of GPx 
total activity, there was a significant decrease at 184.9, 369.8, 739.6 and 1479.2 ng L-1, 
while in the GPx selenium-dependent activity there was a significant increase in 
55 
 
individuals at 92.45 ng L-1, compared with control. Some studies demonstrate that the 
exposure to SIM leads to a decrease in GPx total activity, in very distinct animal models, in 
organisms such as rodents (mg kg-1) (Srinivasa Rao et al., 2012) and humans (10 mg day-1 
during 8 months) (Ungureanu et al., 2003). The significant decrease in GPx total activity 
corroborates the above-mentioned results in terms of the antioxidant properties of SIM 
(Strzyzewski et al., 2013), which may contribute to a reduction of the activity of 
antioxidant enzymes, including GPx. Moreover, while CAT is present in the peroxisomes, 
GPx is located in the cytoplasm. Such as in the case of MnSOD, mostly found in the 
mitochondria, CAT activity was not significantly different from the individuals of the 
control group, which suggests that SIM did not act in the mitochondria to generate 
oxidative stress (Modesto & Martinez, 2010). 
As far as we know, there are no studies regarding GPx selenium-dependent in 
aquatic organisms exposed to statins. The significant increase in selenium-dependent GPx 
activity in individuals exposed to the lowest concentration of SIM could represent an 
increase in H2O2 levels. However, in higher concentrations, the two mechanisms 
mentioned before, i.e. the inhibition of NADPH-oxidase and the increase of nitric oxide 
levels, could have lead to a decrease in ROS, including H2O2, which in turn produced non-
significant results in GPx selenium-dependent activity above this concentration.  
As mentioned before, GSTs are responsible for the conjugation of reduced 
glutathione with electrophilic centers present in endogenous and exogenous compounds, 
leading to the formation of hydrophilic compounds, that can be partially metabolized and 
excreted (Bradford, 1976; Modesto & Martinez, 2010).  
According to the obtained results, individuals exposed to SIM experienced a 
significant decrease in GSTs activity, compared with control organisms. Apart from Cunha 
et al. (2016), that reported an increase in GSTs activity in zebrafish embryos after 
exposure to SIM, to the best of our knowledge, there are no other studies that investigate 
this enzyme’s activity in aquatic organisms exposed to SIM. However, other studies have 
reported similar results to those encountered in this study, where GSTs levels decreased, 
namely in human patients with pancreatic damage, when treated with SIM (Matalka et 
al., 2013; Prokop’eva & Gulyaeva, 2000). There is evidence that in phase 2 of metabolism, 
56 
 
SIM undergoes glucuronidation, i.e., glucuronic acid conjugation by UDP-
glucuronosyltransferases (UGTs) (Prueksaritanont et al., 2002), which leads to the 
conclusion that SIM probably is not metabolized via GSTs. So, SIM should not be 
metabolized in D. rerio via GSTs.  
Alternatively, the role of GSTs is not entirely related to phase II (conjugation) 
metabolism, since GSTs can also prevent the interaction of xenobiotics with nucleic acids 
and proteins, also protecting against oxidative stress and damage (Dzoyem et al., 2014; 
Rahman, 2007; Smith et al., 2013). GSTs are thus antioxidant enzymatic forms that play a 
protective role. The lack of modification of GSTs levels reinforces the previously made 
assumption, concerning the putative absence of clear pro-oxidative effects. In that way, 
as it was mentioned before for SOD and GPx enzymes activity, the antioxidant properties 
of SIM could have led to the hereby observed results. 
As mentioned before, oxidative damage can lead to lipid peroxidation, where free 
radicals interact with lipids containing carbon-carbon double bonds, particularly 
polyunsaturated fatty acids (Halliwell, 2009; Sies, 1985). Considering the results obtained 
for lipid peroxidation there was a significant decrease in this parameter in individuals 
exposed to SIM in levels of 184.9, 369.8, 739.6 and 1479.2 ng.1 L, compared with control. 
As far as we know, there are only a few studies that investigated lipid peroxidation, being 
in the context of treatment of a specific condition with statins and conducted only in 
humans and rodents. Some of these studies reported a decrease in lipid peroxidation, 
through oral administration of SIM, at dosages of 10 mg kg-1 (Mohamadin et al., 2011) 
and administration of 20 mg day-1 during 4 to 12 weeks (Broncel et al., 2006), both 
studies were conducted in humans. The decrease in lipid peroxidation can allow inferring 
the decrease in ROS levels, through the alteration in the process of interaction of free 
radicals with polyunsaturated fatty acids, leading to a decrease in malondialdehyde-like 
compounds. Compounds with antioxidant properties, such as SIM, have been shown to 
lead to less oxidative damage linked to lipid peroxidation (Venturini et al., 2010; Golbidi 
et al., 2011).  
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4.1.3. Sex determination and gonadal developmental stages 
This study was conducted with the primary goal of understanding the potential 
impacts of chronic and acute exposure of simvastatin and clofibric acid in Danio rerio. 
The number of studies about the toxicity of simvastatin in aquatic species in terms of 
endocrine disruption is scarce (Dahl et al., 2006; Neuparth et al., 2014), and none of them 
was performed with Danio rerio. 
Zebrafish gonadal differentiation initiates with a juvenile ovary (Liew & Orbán, 
2014). In zebrafish, genetic sex-determining systems, as well as environmental factors 
seem to regulate the gender of the individuals (Devlin & Nagahama, 2002; Liew et al., 
2012), such as dissolved oxygen (hypoxia) (Shang et al., 2006) and temperature (Abozaid 
et al., 2011; Abozaid et al., 2012; Uchida et al., 2004). At 15 dpf, the juvenile ovary 
develops into ovaries or testes (Pradhan & Olsson, 2016).  
According to the results obtained in terms of sex determination in individuals 
exposed to SIM, no significant differences were found between groups. As far as we 
know, no studies were yet conducted in terms of sex ratio in organisms exposed to this 
pharmaceutical. However, a few studies reported development disruption in Gammarus 
locusta (Neuparth et al., 2014) and harpacticoid copepods (Dahl et al., 2006). HMG-CoA 
reductase inhibitors, such as statins, are thought to affect sex hormone biosynthesis, by 
inhibition of synthesis of cholesterol, a precursor of estradiol and androstenedione (Ser et 
al., 2010). LDLs biosynthesis seems also to be affected by statins. As mentioned before, 
HMG-CoA reductase catalyzes the conversion of HMG-CoA into mevalonic acid. In that 
way, SIM’s inhibition of HMG-CoA reductase leads to a decrease in the production of LDL 
(Rang et al., 2007). LDL is mainly a precursor for ovarian steroid biosynthesis (Vandeputte 
et al., 2007). Thus, statins properties of reduction of LDL can result in a decrease in sex 
hormones, such as androgens and estrogens (Pradhan & Olsson, 2016). In zebrafish, 
estrogen induces ovarian differentiation and maintains femaleness in adulthood, while 
androgen induces testicular differentiation (Pradhan & Olsson, 2016). This means that 
exposure to statins could cause a disruption in the development and gonadal 
differentiation of individuals. Considering the lack of significant results in terms of sex 
determination, and the differences from the results of this assay from others in terms of 
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the development of individuals exposed to SIM, we can assume that major differences in 
terms of development alterations may be due to the distinct levels tested. Development 
changes may only be attained when SIM is present in high levels, such as in these 
investigations, where SIM was used at mg L-1 range, well above the ecologically relevant 
concentrations to which zebrafish were exposed in this assay (ng L-1 range). Moreover, 
taxonomic differences between the tested species and those used in the above-
mentioned investigations could also lead to differences in terms of endocrine disruption. 
As far as we know, there are no assays that investigate particularly gonadal 
maturation after exposure to statins. Zebrafish is an asynchronously spawning fish, which 
means that oocytes and spermatocytes can be observed at various stages of development 
in each individual, which in turn characterize each maturation stage (Okuthe et al., 2014). 
As mentioned before, SIM can decrease LDL levels, which can lead to a decrease in sex 
hormones, such as estrogen and androgen. Estrogen levels can alter gonadotropin 
secretion, which regulates oocyte maturation (Nagahama et al., 1995), while androgens 
stimulate spermatogenesis, i.e., spermatocyte maturation (Singh et al., 1995). Previous 
investigations have shown that statins can interfere with the reproductive development 
of individuals and are able to decrease testosterone levels (Bustan et al., 2017; Leite et 
al., 2014).  Given the lack of results in terms of gonadal maturation phases in females and 
males exposed to SIM, we can assume that SIM did not have any effect in terms of 
reproductive disruption. Although the concentrations used in this assay were based on 
the maximum level found in effluents from WWTPs in Portugal, the range used was at ng 
L-1, which compared to previous studies, might have been a low dosage to produce 
endocrine disruption effects. Moreover, SIM does not seem to have reproductive 
disruption effects, in terms of sex ratio and maturation stages. 
 
 
Considering all the above-mentioned results, in terms of behavior, biochemical 
assessment, and reproductive disruption, in individuals exposed to SIM, we can conclude 
that this compound, in these particular conditions, caused alterations in the first two 
parameters determined, namely behavior and biochemical biomarkers. In terms of 
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behavioural alterations, SIM does not seem to have a well-defined mechanism of action, 
as behavioural alterations may derive from various sources, as mentioned before. 
Locomotion changes seem to be potentially due to alterations in energy deficits 
(biosynthesis of ATP) and neuronal changes, altering movement patterns. On the other 
hand, the biochemical assessment revealed decreasing activity in several enzyme 
activities, such as Cu-Zn SOD, GPx total activity, GSTs, and TBARS. The antioxidant 
properties of SIM might explain this phenomenon, since the presence of an antioxidant 
drug (such as SIM), may counteract the overproduction of ROS, consequently conducting 
to a decrease in the activity of antioxidant enzymes. In that way, the mechanisms behind 
these two biomarkers (behavior and biochemical) do not seem to have a relationship with 
one another. Reproductive disruption through changes in sex ratio and maturation stages 
of individuals exposed to SIM did not reveal any significant differences, compared with 
the control group. The ability of SIM to lower LDL levels should reduce the production of 
sex hormones, such as estrogen and androgen, which ultimately should lead to a lower 
number of juvenile females, through the decrease in estrogen, responsible for the 
maintenance of femaleness in adulthood. However, this outcome was not reported. 
Moreover, a lower concentration of estrogen and androgen should also lead to a 
decrease in ovarian and testicular differentiation, which should be translated in terms of 
maturation stages of individuals. Again, effects of this nature were not observed after 
exposing D. rerio to SIM under the proposed conditions. 
4.2. Clofibric acid 
4.2.1. Behavioral assessment 
As mentioned before, fibrates can interact with hepatic PPARs, that regulate β-
oxidation of fatty acids (Michalik et al., 2006). As far as we know, there are no previous 
investigations regarding the effects of clofibric acid in locomotor ability in early life stages 
of zebrafish in response to stimulation in light-dark transition. 
According to the results obtained for small distance traveled in individuals 
exposed to CA, the general patterns observed were an increase in the first light period, an 
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increase in the first dark cycle and a decrease in the second light and dark periods, 
compared with control.  
Regarding the results for large distance traveled in individuals exposed to CA, the 
overall pattern reported was a decrease in all light and dark cycles, compared with 
control organisms. Energy deficits can cause a decrease in more “vigorous movements” as 
shown by Henriques et al. (2016) in zebrafish exposed to gemfibrozil. 
According to the results obtained in terms of swimming time in organisms exposed 
to CA, the general patterns observed were: relatively similar values in the first light cycle, 
a decrease in the first dark period, and similar values also for the second light and dark 
cycle, compared with the control group. Considering the results in terms of total distance 
traveled in individuals exposed to CA, the overall pattern reported was a decrease in all 
light and dark periods, compared with control. Overall, individuals exposed to CA spent 
more time swimming, however, comparing to the total distance traveled, we can assume 
that organisms swam slower, even though they had more activity than the control group. 
Overall, behavioral effects may result from CA’s mode of action which resulted in a delay 
in the development, directly affecting the physiology and capacity of the individual to 
mobilize nutrients (energy) needed for movements. However, behavior changes in 
locomotor activities depend on various physiological systems (Scott & Sloman, 2004; 
Tierney, 2011). Behavior disruption detected for clofibric acid can, therefore, be derived 
from various sources. Substances that alter the metabolism of nutrients during 
development, such as CA, through changes in beta-oxidation pathways, can have relevant 
consequences on organogenesis (Embrandiri et al., 2016; Henriques et al., 2016).  CA 
interacts with hepatic PPARs, leading to an increase of β-oxidation of fatty acids, and 
consequently to an increment in energy, that can be translated in higher activity of 
individuals, which did not happen in this case, maybe because of the short period of 
exposure to which animals were subjected (Kawashima et al., 1985). As lipid regulator, CA 
may delay embryo development, being more evident at 120 hpf, which can compromise 
the swimming ability of larvae (Henriques et al., 2016). The delayed consumption of the 
yolk sac can also delay the swim bladder inflation and gut morphogenesis, compromising 
locomotor ability (Raldúa et al., 2008). The inhibition of mobilization of nutrients and 
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energy from the yolk sac, as well as the decrease in lipoprotein levels by exposure to CA, 
may limit the capacity for locomotion (Raldúa et al., 2008). 
The discrepancy between animals exposed to lower and higher doses, with a 
decrease followed by an increase in behavioral traits, maybe due to a delay in 
development in larvae exposed to higher doses of CA, which can lead to repercussions in 
locomotor behavior, as it has been described for gemfibrozil by Henriques et al. (2016). 
4.2.2. Biochemical assessment 
According to the results obtained in terms of Cu-Zn SOD activity, there was a 
significant increase in animals exposed to 82.8 and 165.6 µg L-1, while MnSOD activity was 
also significantly increased at 41.4 and 165.6 µg L-1, compared with control. Except for 
some studies with Cyprinus carpio (Corcoran et al., 2015) and Artemia parthenogenetica 
(Nunes et al., 2006), in which SOD activity was not altered, as far as we know, there are 
only a few number of studies that reported similar results in terms of SOD activity, 
namely in Gambusia holbrooki exposed to CA at a mg L-1 range during 96h (Nunes et al., 
2008). Oxygen is consumed in several cellular locations such as the mitochondria, 
endoplasmatic reticulum and peroxisomes, where oxygen is reduced into hydrogen 
peroxide, which is further reduced to H2O (Schrader & Fahimi, 2006). The high 
consumption of molecular oxygen, allied with the production of hydrogen peroxide and 
other free radicals, and the presence of various ROS-metabolizing enzymes, make 
peroxisomes a very important organelle in the production and scavenging of ROS, in 
particular, H2O2 (Schrader & Fahimi, 2006). β-oxidation of fatty acids also contributes to 
the generation of H2O2, which is mainly reduced by CAT into water and molecular oxygen 
(Boveris et al., 1972). The metabolic activity of peroxisomal oxidases leads to the 
production of ROS (Schrader & Fahimi, 2006). As clofibric acid is a peroxisome 
proliferator, it can cause an increase in peroxisome proliferation and β-oxidation of fatty 
acids, leading to the hyperproduction of ROS (Goel et al., 1986; Qu et al., 2001). In that 
way, CA can increase superoxide levels, which in turn increases SOD activity, which 
reduces superoxide into H2O2 and O2. 
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Considering the results obtained in terms of CAT activity, there was a significant 
increase in test organisms exposed to 20.7 µg L-1, followed by a significant decrease at 
165.6 µg L-1, compared with the control group. Several studies also reported an increase 
in CAT activity in individuals exposed to fibrates (Jones & Neill, 1982; Klucis et al., 1984; 
Yang et al., 1990). CAT has been used as an indicative parameter of peroxisome 
proliferation, that constitutes an antioxidant defense, located in the peroxisomes (Aebi, 
1984; Modesto & Martinez, 2010). As a peroxisome proliferator, CA can induce CAT 
(Schrader & Fahimi, 2006). It has been suggested that peroxisome proliferators induce 
the hyperproduction of ROS, in particular, H2O2, which justifies the increase in CAT 
activity (Yeldandi et al., 2000).  However, there was a decrease in CAT activity in animals 
exposed to the highest concentration of CA, which could suggest that other antioxidant 
defenses (such as GPx) could have been involved in the reduction of H2O2 concentrations, 
leading to lower levels of this peroxide in this case. 
According to the results obtained in terms of total GPx activity, there was a 
significant increase at 41.4 µg L-1, while selenium-dependent GPx activity reported a 
significant increase at 41.4 and 165.6 µg L-1. To our knowledge, there are only a few 
studies that report effects in terms of GPx activity in organisms exposed to clofibric acid, 
and only some reported an increase in GPx total activity after exposure to ciprofibrate in 
different subcellular compartments (Dhaunsi, 1994), and an increase in GPx selenium-
dependent in rodents exposed to gemfibrozil (O’Brien et al., 2001). On the other hand, 
there was also a study with Gambusia holbrooki that reported a significant inhibition of 
GPx in fish exposed to clofibric acid at the mg L-1 range (Nunes et al., 2008). As CA can 
stimulate beta-oxidation of fatty acids, with the release of hydrogen peroxide and 
superoxide, as well as other ROS, GPx increase may intend to reduce the levels of 
hydrogen peroxide (Perevoshchikova et al., 2013).  
Considering the results obtained in terms of GSTs activity, there was a significant 
increase in fish exposed to 20.7 and 41.4 µg L-1 of CA, followed by a decrease at 165.6 µg 
L-1, compared with the control group. There are only a few studies that report similar 
results as the ones observed, in organisms exposed to bezafibrate and gemfibrozil, such 
as Mytilus galloprovincialis at ng g-1 range (Canesi et al., 2007) and in Cyprinus carpio 
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exposed to clofibric acid at µg and mg.1 L, where the expression of genes encoding GSTs 
increased (Corcoran et al., 2015). While GPx is more efficient in scavenging H2O2, GSTs 
have more affinity with other organic peroxides (Mannervik & Guthenberg, 1981; 
Levander, 1992). Moreover, H2O2 production in peroxisomes can also lead to the 
formation of other organic peroxides (Mennes et al., 1994). Thus, the increase in CAT 
activity can be related to an excess of H2O2, which in turn produces organic peroxides, 
which can also increase GSTs activity. GSTs are mainly enzymes of phase II 
biotransformation, as they can also indirectly infer oxidative stress. However, there is 
evidence that in phase II of metabolism, CA undergoes glucuronidation in fish, which may 
indicate that this compound is not metabolized strictly via GSTs (Walmsley, 1985). GSTs 
can also detoxify some of the secondary ROS formed when ROS reacts with cells. The 
oxidation of membranes generates toxic reactive compounds that GSTs are able to 
conjugate with glutathione (Veal et al., 2002). Three metabolites have been identified for 
clofibric acid: hydroxyisobutyric acid, lactic acid and 4-chlorophenol (Salgado et al., 2012). 
4-chlorophenol is known to induce GSTs activity as well as the production of ROS 
(Tamburro et al., 2004), which may explain the hereby obtained results. 
Regarding the results obtained in terms of lipid peroxidation, there was a 
significant increase in fish exposed to levels of 41.4 and 165.6 µg L-1, when compared to 
the control. Some studies have reported similar results in terms of lipid peroxidation in 
rodents exposed to ciprofibrate (Goel et al., 1986) and in Gambusia holbrooki exposed to 
clofibric acid (Nunes et al., 2008). Clofibric acid and other peroxisome proliferators 
increase beta-oxidation of fatty acids and peroxisome proliferation, which may result in 
oxidative stress, with the occurrence of lipid peroxidation (Goel et al., 1986). Antioxidant 
defenses prevent the formation of ROS and prevent lipid peroxidation and DNA damage 
(Livingstone, 2003). However, oxidative stress can still arise, leading to lipid peroxidation. 
In this case, the results obtained seem to be due to the hyperproduction of ROS, as a 
consequence of the lack of capacity to neutralize oxidative stress through the previous 
oxidative stress preventive measures, resulting in peroxidative damage. 
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4.2.3. Sex determination and gonadal developmental stages 
To our knowledge, there are few studies that report endocrine disruption in 
aquatic organisms exposed to clofibric acid, and none report the exposure of this 
pharmaceutical in D. rerio. As mentioned before, the fibrate's main function is to reduce 
VLDL and triglycerides, which reduces LDL and increases HDL. They are PPARα agonists, 
which activate lipoprotein lipase and decreases VLDL (Rang et al., 2007). Clofibric acid is 
the hydrolyzed form of clofibrate, being the active metabolite that circulates in plasma 
and believed to be responsible for the hypolipidemic properties of clofibrate (Daughton & 
Ternes, 1999). 
According to the results obtained in terms of sex determination in individuals 
exposed to CA, no significant differences were found, compared with control. However, 
there are contradictory results, compared with other investigations, that report 
endocrine disruption (Runnalls et al., 2007; Coimbra et al., 2015). Apparently, fibrates can 
have estrogenic activity (Isidori et al., 2009), as there was a dose-dependent decrease of 
plasma testosterone in Carassius auratus exposed to 1.5 and 1500 g L-1 (Mimeault et al., 
2006). This would mean a decrease in the number of males and an increase in the 
number of females. Fibrates, being PPARα ligands, can affect reproduction indirectly. 
They can interfere with biosynthesis and breakdown of cholesterol and fatty acids, which 
alters the availability of cholesterol for the production of steroids (Cameron et al., 2011; 
Velasco-Santamaría et al., 2011; Manibusan & Touart, 2017). Fibrates seem to impact in 
cholesterol movement, by interfering in the release of cAMP and the mitochondrial 
transport of cholesterol, limiting steps of steroidogenesis (Gazouli et al., 2002; Cameron 
et al., 2011). There was also a study that reported a male-biased population in individuals 
exposed to CA at 1 and 10 mg g-1 (through food) (Coimbra et al., 2015). This evidence 
could suggest that the exposure to CA would cause a disruption in development and, 
therefore, in gonadal differentiation of individuals. Considering the lack of significant 
results in terms of sex determination, and the differences from the results of this assay 
from others in terms of reproductive disruption in individuals exposed to CA, we can 
assume that major differences in terms of development alterations may be due to the 
variations in concentrations, exposure and model organisms tested. 
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Considering the results obtained in terms of female and male developmental 
stages, there were also no significant differences, compared with control. However, other 
studies reported different results in terms of female maturation stages, where there was 
a suppression of the expression of genes involved in steroidogenesis by exposure to 
fibrates (Toda et al., 2003). Ovarian follicle development is composed of two phases: 
follicular growth, where the immature oocyte grows in size, and a maturation stage, 
where immature oocytes transition into a mature egg (Selman et al., 1993). According to 
(Ibabe et al., 2005), there are three PPARs (α, β, and γ) in the zebrafish ovary. Their 
expression decreases follicular development (Ibabe et al., 2005). PPARα seems to be 
involved in regulating follicular growth and maturation (Komar et al., 2001; Komar, 2005). 
As PPARα agonists, fibrates can alter these processes (Rang et al., 2007). PPARs in Sertoli 
and Leydig cells seem to have a role in spermatogenesis and to be directly involved in 
maturation (Ibabe et al., 2005). Thus, PPAR ligands can affect spermatogenesis and sperm 
activities (Huang, 2008). 
Differences in terms of tested organisms, duration of exposure and concentrations 
may explain the lack of results in terms of female and male maturation stages, after 
exposure to CA.  
 
Considering all the above-mentioned results, in terms of behavior, biochemical 
assessment, and reproductive disruption, for individuals exposed to CA, we can conclude 
that this compound, in these particular conditions, caused alterations in the first two 
biomarkers (behavior and biochemical) determined. 
In terms of behavioral alterations and according with the information mentioned 
before, the decrease in activity seems to be related to the lack of nutrient mobilization 
and energy, with lower lipoprotein levels, that were reflected in delayed development of 
the individual, and consequently of its swimming ability. (Handy et al., 1999), also 
reported that metabolic costs due to detoxification processes can also compromise 
locomotory responses of individuals, which could also explain the behavioral changes 
observed. On the other hand, the biochemical assessment revealed increased activity in 
several enzyme activities, such as SOD, CAT, GPx, which constitutes evidence for oxidative 
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stress. Moreover, GSTs increased activity also suggests the occurrence of conjugation and 
biotransformation (phase II) and the increase in lipid peroxidation levels (TBARS) indicate 
peroxidative damage in individuals. As mentioned before, the metabolic activity of 
peroxisomal oxidases leads to the hyperproduction of ROS. Moreover, CA can produce 
three metabolites, being one of them 4-chlorophenol, which is also known to induce the 
production of ROS. In that way, the increase in ROS levels leads to an increase in 
antioxidant enzyme activity. Reproductive disruption through changes in sex ratio and 
maturation stages of individuals exposed to CA did not reveal any significant differences, 
compared with the control group. As a PPAR ligand, CA should be able to affect 
spermatogenesis, as well as follicular growth and maturation, which does not seem to 
have happened in this case. 
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5. CONCLUSION 
Ecotoxicological data for lipid-regulating drugs, such as simvastatin, are still 
lacking, and these drugs have only been confusingly characterized in terms of modes of 
action and consequences in aquatic organisms. This assay provided information about the 
ecotoxicity of two lipid-regulating drugs, simvastatin, and clofibric acid, in both embryonic 
and juvenile stages of D. rerio, which are of ecological relevance. Results from this study 
prove that zebrafish early-life stages and juvenile individuals can serve as model 
organisms in ecotoxicological assays (Scholz et al., 2008; Lammer et al., 2009). This 
species is easy to maintain, and behavioral responses can be monitored with high 
precision. Ecotoxicity assessment can be easily determined in zebrafish larvae, which 
makes it a relevant tool for this type of investigation. Lipid-regulating drugs, such as those 
used in this assay, are still lacking and confusingly characterized in terms of modes of 
action and consequences in aquatic organisms. 
Overall, zebrafish larvae were more sensitive to the exposure to clofibric acid, 
which showed hypoactivity and prooxidant effects, while simvastatin caused 
hyperactivity, and antioxidant effects. Thus, oxidative stress responses, as well as lipid 
peroxidation effects, seem to be related to behavioral changes in individuals. In terms of 
reproductive disruption, no evident alterations were reported after the here-defined 
exposure conditions to both compounds. 
Statins and fibrates have different properties, including their mechanism of action 
and especially metabolism, which could explain the distinct results obtained for both 
compounds. The results here obtained, with concentrations of ecological relevance of 
these two pharmaceuticals, can suggest deleterious effects in non-target individuals. 
Further investigations with other methods for endocrine disruption assessment in adult 
individuals exposed to simvastatin and clofibric acid, e.g. the quantification of vitellogenin 
content, should be relevant to determine the role of these lipid-lowering drugs in the 
reproductive disruption, if there is one. Moreover, cholinesterase activity could be a good 
endpoint to determine if there is a relationship between these enzymes activity and 
behavioral effects in both compounds. 
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In summary, this assay contributes to a better understanding of the effects of these lipid-
regulating drugs, often present in the aquatic compartment, on zebrafish individuals. The 
tools here developed, overall seem to be highly responsive and may be relevant in the 
ecotoxicological assessment of xenobiotics in the aquatic environment. 
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